id	sid	tid	token	lemma	pos
cord-288020-vhtr3l0w	1	1	key	key	JJ
cord-288020-vhtr3l0w	1	2	:	:	:
cord-288020-vhtr3l0w	1	3	cord-288020-vhtr3l0w	cord-288020-vhtr3l0w	NN
cord-288020-vhtr3l0w	2	1	authors	author	NNS
cord-288020-vhtr3l0w	2	2	:	:	:
cord-288020-vhtr3l0w	2	3	Côté	Côté	NNP
cord-288020-vhtr3l0w	2	4	,	,	,
cord-288020-vhtr3l0w	2	5	Andréanne	Andréanne	NNP
cord-288020-vhtr3l0w	2	6	;	;	:
cord-288020-vhtr3l0w	2	7	Ternacle	Ternacle	NNP
cord-288020-vhtr3l0w	2	8	,	,	,
cord-288020-vhtr3l0w	2	9	Julien	Julien	NNP
cord-288020-vhtr3l0w	2	10	;	;	:
cord-288020-vhtr3l0w	2	11	Pibarot	Pibarot	NNP
cord-288020-vhtr3l0w	2	12	,	,	,
cord-288020-vhtr3l0w	2	13	Philippe	Philippe	NNP
cord-288020-vhtr3l0w	2	14	title	title	NN
cord-288020-vhtr3l0w	2	15	:	:	:
cord-288020-vhtr3l0w	2	16	Early	early	JJ
cord-288020-vhtr3l0w	2	17	prediction	prediction	NN
cord-288020-vhtr3l0w	2	18	of	of	IN
cord-288020-vhtr3l0w	2	19	the	the	DT
cord-288020-vhtr3l0w	2	20	risk	risk	NN
cord-288020-vhtr3l0w	2	21	of	of	IN
cord-288020-vhtr3l0w	2	22	severe	severe	JJ
cord-288020-vhtr3l0w	2	23	coronavirus	coronavirus	NN
cord-288020-vhtr3l0w	2	24	disease	disease	NN
cord-288020-vhtr3l0w	2	25	2019	2019	CD
cord-288020-vhtr3l0w	2	26	:	:	:
cord-288020-vhtr3l0w	3	1	A	a	DT
cord-288020-vhtr3l0w	3	2	key	key	JJ
cord-288020-vhtr3l0w	3	3	step	step	NN
cord-288020-vhtr3l0w	3	4	in	in	IN
cord-288020-vhtr3l0w	3	5	therapeutic	therapeutic	JJ
cord-288020-vhtr3l0w	3	6	decision	decision	NN
cord-288020-vhtr3l0w	3	7	making	make	VBG
cord-288020-vhtr3l0w	3	8	date	date	NN
cord-288020-vhtr3l0w	3	9	:	:	:
cord-288020-vhtr3l0w	3	10	2020	2020	CD
cord-288020-vhtr3l0w	3	11	-	-	HYPH
cord-288020-vhtr3l0w	3	12	08	08	CD
cord-288020-vhtr3l0w	3	13	-	-	SYM
cord-288020-vhtr3l0w	3	14	15	15	CD
cord-288020-vhtr3l0w	3	15	journal	journal	NN
cord-288020-vhtr3l0w	3	16	:	:	:
cord-288020-vhtr3l0w	4	1	EBioMedicine	ebiomedicine	NN
cord-288020-vhtr3l0w	4	2	DOI	DOI	NNP
cord-288020-vhtr3l0w	4	3	:	:	:
cord-288020-vhtr3l0w	4	4	10.1016	10.1016	CD
cord-288020-vhtr3l0w	4	5	/	/	SYM
cord-288020-vhtr3l0w	4	6	j.ebiom.2020.102948	j.ebiom.2020.102948	NN
cord-288020-vhtr3l0w	4	7	sha	sha	NNP
cord-288020-vhtr3l0w	4	8	:	:	:
cord-288020-vhtr3l0w	4	9	26fdc6de719fdf960b3fa80032402c2deebac7e3	26fdc6de719fdf960b3fa80032402c2deebac7e3	NNP
cord-288020-vhtr3l0w	4	10	doc_id	doc_id	CD
cord-288020-vhtr3l0w	4	11	:	:	:
cord-288020-vhtr3l0w	4	12	288020	288020	CD
cord-288020-vhtr3l0w	4	13	cord_uid	cord_uid	NNS
cord-288020-vhtr3l0w	4	14	:	:	:
cord-288020-vhtr3l0w	5	1	vhtr3l0w	vhtr3l0w	JJ
cord-288020-vhtr3l0w	6	1	nan	nan	NNP
cord-288020-vhtr3l0w	6	2	Article	Article	NNP
cord-288020-vhtr3l0w	6	3	History	history	NN
cord-288020-vhtr3l0w	6	4	:	:	:
cord-288020-vhtr3l0w	6	5	Received	receive	VBD
cord-288020-vhtr3l0w	6	6	11	11	CD
cord-288020-vhtr3l0w	6	7	July	July	NNP
cord-288020-vhtr3l0w	6	8	2020	2020	CD
cord-288020-vhtr3l0w	7	1	Accepted	accept	VBN
cord-288020-vhtr3l0w	7	2	28	28	CD
cord-288020-vhtr3l0w	7	3	July	July	NNP
cord-288020-vhtr3l0w	7	4	2020	2020	CD
cord-288020-vhtr3l0w	8	1	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	8	2	is	be	VBZ
cord-288020-vhtr3l0w	8	3	caused	cause	VBN
cord-288020-vhtr3l0w	8	4	by	by	IN
cord-288020-vhtr3l0w	8	5	the	the	DT
cord-288020-vhtr3l0w	8	6	SARS	SARS	NNP
cord-288020-vhtr3l0w	8	7	-	-	HYPH
cord-288020-vhtr3l0w	8	8	COV-2	COV-2	NNP
cord-288020-vhtr3l0w	8	9	virus	virus	NN
cord-288020-vhtr3l0w	8	10	and	and	CC
cord-288020-vhtr3l0w	8	11	leads	lead	VBZ
cord-288020-vhtr3l0w	8	12	to	to	IN
cord-288020-vhtr3l0w	8	13	primarily	primarily	RB
cord-288020-vhtr3l0w	8	14	respiratory	respiratory	JJ
cord-288020-vhtr3l0w	8	15	symptoms	symptom	NNS
cord-288020-vhtr3l0w	8	16	.	.	.
cord-288020-vhtr3l0w	9	1	So	so	RB
cord-288020-vhtr3l0w	9	2	far	far	RB
cord-288020-vhtr3l0w	9	3	,	,	,
cord-288020-vhtr3l0w	9	4	a	a	DT
cord-288020-vhtr3l0w	9	5	wide	wide	JJ
cord-288020-vhtr3l0w	9	6	range	range	NN
cord-288020-vhtr3l0w	9	7	of	of	IN
cord-288020-vhtr3l0w	9	8	clinical	clinical	JJ
cord-288020-vhtr3l0w	9	9	manifestations	manifestation	NNS
cord-288020-vhtr3l0w	9	10	have	have	VBP
cord-288020-vhtr3l0w	9	11	been	be	VBN
cord-288020-vhtr3l0w	9	12	reported	report	VBN
cord-288020-vhtr3l0w	9	13	from	from	IN
cord-288020-vhtr3l0w	9	14	complete	complete	JJ
cord-288020-vhtr3l0w	9	15	lack	lack	NN
cord-288020-vhtr3l0w	9	16	of	of	IN
cord-288020-vhtr3l0w	9	17	symptoms	symptom	NNS
cord-288020-vhtr3l0w	9	18	to	to	IN
cord-288020-vhtr3l0w	9	19	life	life	NN
cord-288020-vhtr3l0w	9	20	-	-	HYPH
cord-288020-vhtr3l0w	9	21	threatening	threaten	VBG
cord-288020-vhtr3l0w	9	22	multiple	multiple	JJ
cord-288020-vhtr3l0w	9	23	organ	organ	NN
cord-288020-vhtr3l0w	9	24	failure	failure	NN
cord-288020-vhtr3l0w	9	25	.	.	.
cord-288020-vhtr3l0w	10	1	Currently	currently	RB
cord-288020-vhtr3l0w	10	2	,	,	,
cord-288020-vhtr3l0w	10	3	therapeutic	therapeutic	JJ
cord-288020-vhtr3l0w	10	4	management	management	NN
cord-288020-vhtr3l0w	10	5	is	be	VBZ
cord-288020-vhtr3l0w	10	6	mainly	mainly	RB
cord-288020-vhtr3l0w	10	7	supportive	supportive	JJ
cord-288020-vhtr3l0w	10	8	and	and	CC
cord-288020-vhtr3l0w	10	9	primarily	primarily	RB
cord-288020-vhtr3l0w	10	10	driven	drive	VBN
cord-288020-vhtr3l0w	10	11	by	by	IN
cord-288020-vhtr3l0w	10	12	the	the	DT
cord-288020-vhtr3l0w	10	13	presence	presence	NN
cord-288020-vhtr3l0w	10	14	and	and	CC
cord-288020-vhtr3l0w	10	15	severity	severity	NN
cord-288020-vhtr3l0w	10	16	of	of	IN
cord-288020-vhtr3l0w	10	17	an	an	DT
cord-288020-vhtr3l0w	10	18	individual	individual	NN
cord-288020-vhtr3l0w	10	19	's	's	POS
cord-288020-vhtr3l0w	10	20	symptoms	symptom	NNS
cord-288020-vhtr3l0w	10	21	.	.	.
cord-288020-vhtr3l0w	11	1	It	-PRON-	PRP
cord-288020-vhtr3l0w	11	2	is	be	VBZ
cord-288020-vhtr3l0w	11	3	becoming	become	VBG
cord-288020-vhtr3l0w	11	4	increasingly	increasingly	RB
cord-288020-vhtr3l0w	11	5	obvious	obvious	JJ
cord-288020-vhtr3l0w	11	6	that	that	IN
cord-288020-vhtr3l0w	11	7	a	a	DT
cord-288020-vhtr3l0w	11	8	substantial	substantial	JJ
cord-288020-vhtr3l0w	11	9	proportion	proportion	NN
cord-288020-vhtr3l0w	11	10	of	of	IN
cord-288020-vhtr3l0w	11	11	patients	patient	NNS
cord-288020-vhtr3l0w	11	12	initially	initially	RB
cord-288020-vhtr3l0w	11	13	presenting	present	VBG
cord-288020-vhtr3l0w	11	14	with	with	IN
cord-288020-vhtr3l0w	11	15	mild	mild	JJ
cord-288020-vhtr3l0w	11	16	symptoms	symptom	NNS
cord-288020-vhtr3l0w	11	17	are	be	VBP
cord-288020-vhtr3l0w	11	18	at	at	IN
cord-288020-vhtr3l0w	11	19	increased	increase	VBN
cord-288020-vhtr3l0w	11	20	risk	risk	NN
cord-288020-vhtr3l0w	11	21	of	of	IN
cord-288020-vhtr3l0w	11	22	developing	develop	VBG
cord-288020-vhtr3l0w	11	23	severe	severe	JJ
cord-288020-vhtr3l0w	11	24	disease	disease	NN
cord-288020-vhtr3l0w	11	25	and	and	CC
cord-288020-vhtr3l0w	11	26	would	would	MD
cord-288020-vhtr3l0w	11	27	benefit	benefit	VB
cord-288020-vhtr3l0w	11	28	from	from	IN
cord-288020-vhtr3l0w	11	29	early	early	RB
cord-288020-vhtr3l0w	11	30	and	and	CC
cord-288020-vhtr3l0w	11	31	more	more	RBR
cord-288020-vhtr3l0w	11	32	aggressive	aggressive	JJ
cord-288020-vhtr3l0w	11	33	intervention	intervention	NN
cord-288020-vhtr3l0w	11	34	.	.	.
cord-288020-vhtr3l0w	12	1	There	there	EX
cord-288020-vhtr3l0w	12	2	is	be	VBZ
cord-288020-vhtr3l0w	12	3	thus	thus	RB
cord-288020-vhtr3l0w	12	4	a	a	DT
cord-288020-vhtr3l0w	12	5	need	need	NN
cord-288020-vhtr3l0w	12	6	to	to	TO
cord-288020-vhtr3l0w	12	7	develop	develop	VB
cord-288020-vhtr3l0w	12	8	and	and	CC
cord-288020-vhtr3l0w	12	9	validate	validate	VB
cord-288020-vhtr3l0w	12	10	risk	risk	NN
cord-288020-vhtr3l0w	12	11	stratification	stratification	NN
cord-288020-vhtr3l0w	12	12	models	model	NNS
cord-288020-vhtr3l0w	12	13	that	that	WDT
cord-288020-vhtr3l0w	12	14	can	can	MD
cord-288020-vhtr3l0w	12	15	provide	provide	VB
cord-288020-vhtr3l0w	12	16	early	early	JJ
cord-288020-vhtr3l0w	12	17	prediction	prediction	NN
cord-288020-vhtr3l0w	12	18	of	of	IN
cord-288020-vhtr3l0w	12	19	those	those	DT
cord-288020-vhtr3l0w	12	20	individuals	individual	NNS
cord-288020-vhtr3l0w	12	21	who	who	WP
cord-288020-vhtr3l0w	12	22	are	be	VBP
cord-288020-vhtr3l0w	12	23	at	at	IN
cord-288020-vhtr3l0w	12	24	risk	risk	NN
cord-288020-vhtr3l0w	12	25	of	of	IN
cord-288020-vhtr3l0w	12	26	developing	develop	VBG
cord-288020-vhtr3l0w	12	27	a	a	DT
cord-288020-vhtr3l0w	12	28	severe	severe	JJ
cord-288020-vhtr3l0w	12	29	disease	disease	NN
cord-288020-vhtr3l0w	12	30	.	.	.
cord-288020-vhtr3l0w	13	1	In	in	IN
cord-288020-vhtr3l0w	13	2	an	an	DT
cord-288020-vhtr3l0w	13	3	article	article	NN
cord-288020-vhtr3l0w	13	4	published	publish	VBN
cord-288020-vhtr3l0w	13	5	in	in	IN
cord-288020-vhtr3l0w	13	6	the	the	DT
cord-288020-vhtr3l0w	13	7	July	July	NNP
cord-288020-vhtr3l0w	13	8	issue	issue	NN
cord-288020-vhtr3l0w	13	9	of	of	IN
cord-288020-vhtr3l0w	13	10	EBioMedicine	EBioMedicine	NNP
cord-288020-vhtr3l0w	13	11	,	,	,
cord-288020-vhtr3l0w	13	12	Xiao	Xiao	NNP
cord-288020-vhtr3l0w	13	13	et	et	NNP
cord-288020-vhtr3l0w	13	14	al	al	NNP
cord-288020-vhtr3l0w	13	15	.	.	.
cord-288020-vhtr3l0w	14	1	propose	propose	VB
cord-288020-vhtr3l0w	14	2	a	a	DT
cord-288020-vhtr3l0w	14	3	novel	novel	JJ
cord-288020-vhtr3l0w	14	4	risk	risk	NN
cord-288020-vhtr3l0w	14	5	score	score	NN
cord-288020-vhtr3l0w	14	6	for	for	IN
cord-288020-vhtr3l0w	14	7	this	this	DT
cord-288020-vhtr3l0w	14	8	purpose	purpose	NN
cord-288020-vhtr3l0w	14	9	;	;	:
cord-288020-vhtr3l0w	14	10	the	the	DT
cord-288020-vhtr3l0w	14	11	HNC	HNC	NNP
cord-288020-vhtr3l0w	14	12	-	-	HYPH
cord-288020-vhtr3l0w	14	13	LL	LL	NNP
cord-288020-vhtr3l0w	14	14	score	score	NN
cord-288020-vhtr3l0w	14	15	[	[	-LRB-
cord-288020-vhtr3l0w	14	16	1	1	CD
cord-288020-vhtr3l0w	14	17	]	]	-RRB-
cord-288020-vhtr3l0w	14	18	.	.	.
cord-288020-vhtr3l0w	15	1	Specifically	specifically	RB
cord-288020-vhtr3l0w	15	2	,	,	,
cord-288020-vhtr3l0w	15	3	the	the	DT
cord-288020-vhtr3l0w	15	4	HNC	HNC	NNP
cord-288020-vhtr3l0w	15	5	-	-	HYPH
cord-288020-vhtr3l0w	15	6	LL	LL	NNP
cord-288020-vhtr3l0w	15	7	score	score	NN
cord-288020-vhtr3l0w	15	8	includes	include	VBZ
cord-288020-vhtr3l0w	15	9	hypertension	hypertension	NN
cord-288020-vhtr3l0w	15	10	,	,	,
cord-288020-vhtr3l0w	15	11	neutrophil	neutrophil	NN
cord-288020-vhtr3l0w	15	12	count	count	NN
cord-288020-vhtr3l0w	15	13	,	,	,
cord-288020-vhtr3l0w	15	14	C	C	NNP
cord-288020-vhtr3l0w	15	15	-	-	HYPH
cord-288020-vhtr3l0w	15	16	Reactive	Reactive	NNP
cord-288020-vhtr3l0w	15	17	Protein	Protein	NNP
cord-288020-vhtr3l0w	15	18	(	(	-LRB-
cord-288020-vhtr3l0w	15	19	CRP	CRP	NNP
cord-288020-vhtr3l0w	15	20	)	)	-RRB-
cord-288020-vhtr3l0w	15	21	,	,	,
cord-288020-vhtr3l0w	15	22	lymphocyte	lymphocyte	NN
cord-288020-vhtr3l0w	15	23	count	count	NN
cord-288020-vhtr3l0w	15	24	,	,	,
cord-288020-vhtr3l0w	15	25	and	and	CC
cord-288020-vhtr3l0w	15	26	lactate	lactate	NN
cord-288020-vhtr3l0w	15	27	dehydrogenase	dehydrogenase	NN
cord-288020-vhtr3l0w	15	28	.	.	.
cord-288020-vhtr3l0w	16	1	Their	-PRON-	PRP$
cord-288020-vhtr3l0w	16	2	retrospective	retrospective	JJ
cord-288020-vhtr3l0w	16	3	study	study	NN
cord-288020-vhtr3l0w	16	4	included	include	VBD
cord-288020-vhtr3l0w	16	5	690	690	CD
cord-288020-vhtr3l0w	16	6	patients	patient	NNS
cord-288020-vhtr3l0w	16	7	from	from	IN
cord-288020-vhtr3l0w	16	8	hospitals	hospital	NNS
cord-288020-vhtr3l0w	16	9	in	in	IN
cord-288020-vhtr3l0w	16	10	Honghu	Honghu	NNP
cord-288020-vhtr3l0w	16	11	and	and	CC
cord-288020-vhtr3l0w	16	12	Nanchang	Nanchang	NNP
cord-288020-vhtr3l0w	16	13	,	,	,
cord-288020-vhtr3l0w	16	14	China	China	NNP
cord-288020-vhtr3l0w	16	15	.	.	.
cord-288020-vhtr3l0w	17	1	The	the	DT
cord-288020-vhtr3l0w	17	2	stratification	stratification	NN
cord-288020-vhtr3l0w	17	3	results	result	NNS
cord-288020-vhtr3l0w	17	4	showed	show	VBD
cord-288020-vhtr3l0w	17	5	good	good	JJ
cord-288020-vhtr3l0w	17	6	accuracy	accuracy	NN
cord-288020-vhtr3l0w	17	7	(	(	-LRB-
cord-288020-vhtr3l0w	17	8	Area	area	NN
cord-288020-vhtr3l0w	17	9	under	under	IN
cord-288020-vhtr3l0w	17	10	the	the	DT
cord-288020-vhtr3l0w	17	11	Receiver	Receiver	NNP
cord-288020-vhtr3l0w	17	12	Operating	Operating	NNP
cord-288020-vhtr3l0w	17	13	Characteristic	characteristic	JJ
cord-288020-vhtr3l0w	17	14	curve	curve	NN
cord-288020-vhtr3l0w	17	15	>	>	XX
cord-288020-vhtr3l0w	17	16	0.85	0.85	CD
cord-288020-vhtr3l0w	17	17	)	)	-RRB-
cord-288020-vhtr3l0w	17	18	to	to	TO
cord-288020-vhtr3l0w	17	19	predict	predict	VB
cord-288020-vhtr3l0w	17	20	severe	severe	JJ
cord-288020-vhtr3l0w	17	21	disease	disease	NN
cord-288020-vhtr3l0w	17	22	in	in	IN
cord-288020-vhtr3l0w	17	23	both	both	CC
cord-288020-vhtr3l0w	17	24	the	the	DT
cord-288020-vhtr3l0w	17	25	training	training	NN
cord-288020-vhtr3l0w	17	26	and	and	CC
cord-288020-vhtr3l0w	17	27	validation	validation	NN
cord-288020-vhtr3l0w	17	28	cohorts	cohort	NNS
cord-288020-vhtr3l0w	17	29	.	.	.
cord-288020-vhtr3l0w	18	1	The	the	DT
cord-288020-vhtr3l0w	18	2	main	main	JJ
cord-288020-vhtr3l0w	18	3	strength	strength	NN
cord-288020-vhtr3l0w	18	4	is	be	VBZ
cord-288020-vhtr3l0w	18	5	the	the	DT
cord-288020-vhtr3l0w	18	6	simplicity	simplicity	NN
cord-288020-vhtr3l0w	18	7	of	of	IN
cord-288020-vhtr3l0w	18	8	application	application	NN
cord-288020-vhtr3l0w	18	9	in	in	IN
cord-288020-vhtr3l0w	18	10	the	the	DT
cord-288020-vhtr3l0w	18	11	clinical	clinical	JJ
cord-288020-vhtr3l0w	18	12	setting	setting	NN
cord-288020-vhtr3l0w	18	13	,	,	,
cord-288020-vhtr3l0w	18	14	whereby	whereby	WRB
cord-288020-vhtr3l0w	18	15	it	-PRON-	PRP
cord-288020-vhtr3l0w	18	16	has	have	VBZ
cord-288020-vhtr3l0w	18	17	the	the	DT
cord-288020-vhtr3l0w	18	18	advantage	advantage	NN
cord-288020-vhtr3l0w	18	19	of	of	IN
cord-288020-vhtr3l0w	18	20	including	include	VBG
cord-288020-vhtr3l0w	18	21	a	a	DT
cord-288020-vhtr3l0w	18	22	small	small	JJ
cord-288020-vhtr3l0w	18	23	number	number	NN
cord-288020-vhtr3l0w	18	24	of	of	IN
cord-288020-vhtr3l0w	18	25	parameters	parameter	NNS
cord-288020-vhtr3l0w	18	26	that	that	WDT
cord-288020-vhtr3l0w	18	27	are	be	VBP
cord-288020-vhtr3l0w	18	28	easily	easily	RB
cord-288020-vhtr3l0w	18	29	and	and	CC
cord-288020-vhtr3l0w	18	30	routinely	routinely	RB
cord-288020-vhtr3l0w	18	31	measured	measure	VBN
cord-288020-vhtr3l0w	18	32	in	in	IN
cord-288020-vhtr3l0w	18	33	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	18	34	patients	patient	NNS
cord-288020-vhtr3l0w	18	35	with	with	IN
cord-288020-vhtr3l0w	18	36	respiratory	respiratory	JJ
cord-288020-vhtr3l0w	18	37	infections	infection	NNS
cord-288020-vhtr3l0w	18	38	.	.	.
cord-288020-vhtr3l0w	19	1	Furthermore	furthermore	RB
cord-288020-vhtr3l0w	19	2	,	,	,
cord-288020-vhtr3l0w	19	3	the	the	DT
cord-288020-vhtr3l0w	19	4	HNC	HNC	NNP
cord-288020-vhtr3l0w	19	5	-	-	HYPH
cord-288020-vhtr3l0w	19	6	LL	LL	NNP
cord-288020-vhtr3l0w	19	7	appears	appear	VBZ
cord-288020-vhtr3l0w	19	8	to	to	TO
cord-288020-vhtr3l0w	19	9	outperform	outperform	VB
cord-288020-vhtr3l0w	19	10	comparable	comparable	JJ
cord-288020-vhtr3l0w	19	11	scores	score	NNS
cord-288020-vhtr3l0w	19	12	that	that	WDT
cord-288020-vhtr3l0w	19	13	have	have	VBP
cord-288020-vhtr3l0w	19	14	been	be	VBN
cord-288020-vhtr3l0w	19	15	proposed	propose	VBN
cord-288020-vhtr3l0w	19	16	during	during	IN
cord-288020-vhtr3l0w	19	17	the	the	DT
cord-288020-vhtr3l0w	19	18	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	19	19	pandemic	pandemic	NN
cord-288020-vhtr3l0w	19	20	,	,	,
cord-288020-vhtr3l0w	19	21	such	such	JJ
cord-288020-vhtr3l0w	19	22	as	as	IN
cord-288020-vhtr3l0w	19	23	the	the	DT
cord-288020-vhtr3l0w	19	24	CURB-65	CURB-65	NNP
cord-288020-vhtr3l0w	19	25	score	score	NN
cord-288020-vhtr3l0w	19	26	(	(	-LRB-
cord-288020-vhtr3l0w	19	27	confusion	confusion	NN
cord-288020-vhtr3l0w	19	28	,	,	,
cord-288020-vhtr3l0w	19	29	urea	urea	NN
cord-288020-vhtr3l0w	19	30	,	,	,
cord-288020-vhtr3l0w	19	31	respiratory	respiratory	JJ
cord-288020-vhtr3l0w	19	32	rate	rate	NN
cord-288020-vhtr3l0w	19	33	,	,	,
cord-288020-vhtr3l0w	19	34	blood	blood	NN
cord-288020-vhtr3l0w	19	35	pressure	pressure	NN
cord-288020-vhtr3l0w	19	36	,	,	,
cord-288020-vhtr3l0w	19	37	65	65	CD
cord-288020-vhtr3l0w	19	38	years	year	NNS
cord-288020-vhtr3l0w	19	39	)	)	-RRB-
cord-288020-vhtr3l0w	19	40	,	,	,
cord-288020-vhtr3l0w	19	41	the	the	DT
cord-288020-vhtr3l0w	19	42	MuLBSTA	MuLBSTA	NNP
cord-288020-vhtr3l0w	19	43	score	score	NN
cord-288020-vhtr3l0w	19	44	(	(	-LRB-
cord-288020-vhtr3l0w	19	45	multilobular	multilobular	JJ
cord-288020-vhtr3l0w	19	46	infiltration	infiltration	NN
cord-288020-vhtr3l0w	19	47	,	,	,
cord-288020-vhtr3l0w	19	48	hypo	hypo	NN
cord-288020-vhtr3l0w	19	49	-	-	HYPH
cord-288020-vhtr3l0w	19	50	lymphocytosis	lymphocytosis	JJ
cord-288020-vhtr3l0w	19	51	,	,	,
cord-288020-vhtr3l0w	19	52	bacterial	bacterial	JJ
cord-288020-vhtr3l0w	19	53	coinfection	coinfection	NN
cord-288020-vhtr3l0w	19	54	,	,	,
cord-288020-vhtr3l0w	19	55	smoking	smoke	VBG
cord-288020-vhtr3l0w	19	56	history	history	NN
cord-288020-vhtr3l0w	19	57	,	,	,
cord-288020-vhtr3l0w	19	58	hypertension	hypertension	NN
cord-288020-vhtr3l0w	19	59	,	,	,
cord-288020-vhtr3l0w	19	60	and	and	CC
cord-288020-vhtr3l0w	19	61	age	age	NN
cord-288020-vhtr3l0w	19	62	)	)	-RRB-
cord-288020-vhtr3l0w	19	63	and	and	CC
cord-288020-vhtr3l0w	19	64	the	the	DT
cord-288020-vhtr3l0w	19	65	neutrophil	neutrophil	NN
cord-288020-vhtr3l0w	19	66	-	-	HYPH
cord-288020-vhtr3l0w	19	67	to	to	IN
cord-288020-vhtr3l0w	19	68	-	-	HYPH
cord-288020-vhtr3l0w	19	69	lymphocyte	lymphocyte	NN
cord-288020-vhtr3l0w	19	70	ratio	ratio	NN
cord-288020-vhtr3l0w	19	71	.	.	.
cord-288020-vhtr3l0w	20	1	Importantly	importantly	RB
cord-288020-vhtr3l0w	20	2	,	,	,
cord-288020-vhtr3l0w	20	3	the	the	DT
cord-288020-vhtr3l0w	20	4	HNC	HNC	NNP
cord-288020-vhtr3l0w	20	5	-	-	HYPH
cord-288020-vhtr3l0w	20	6	LL	LL	NNP
cord-288020-vhtr3l0w	20	7	score	score	NN
cord-288020-vhtr3l0w	20	8	also	also	RB
cord-288020-vhtr3l0w	20	9	had	have	VBD
cord-288020-vhtr3l0w	20	10	a	a	DT
cord-288020-vhtr3l0w	20	11	good	good	JJ
cord-288020-vhtr3l0w	20	12	predictive	predictive	JJ
cord-288020-vhtr3l0w	20	13	ability	ability	NN
cord-288020-vhtr3l0w	20	14	to	to	TO
cord-288020-vhtr3l0w	20	15	identify	identify	VB
cord-288020-vhtr3l0w	20	16	those	those	DT
cord-288020-vhtr3l0w	20	17	patients	patient	NNS
cord-288020-vhtr3l0w	20	18	who	who	WP
cord-288020-vhtr3l0w	20	19	were	be	VBD
cord-288020-vhtr3l0w	20	20	admitted	admit	VBN
cord-288020-vhtr3l0w	20	21	to	to	IN
cord-288020-vhtr3l0w	20	22	hospital	hospital	NN
cord-288020-vhtr3l0w	20	23	with	with	IN
cord-288020-vhtr3l0w	20	24	mild	mild	JJ
cord-288020-vhtr3l0w	20	25	disease	disease	NN
cord-288020-vhtr3l0w	20	26	and	and	CC
cord-288020-vhtr3l0w	20	27	progressed	progress	VBD
cord-288020-vhtr3l0w	20	28	to	to	IN
cord-288020-vhtr3l0w	20	29	a	a	DT
cord-288020-vhtr3l0w	20	30	severe	severe	JJ
cord-288020-vhtr3l0w	20	31	disease	disease	NN
cord-288020-vhtr3l0w	20	32	during	during	IN
cord-288020-vhtr3l0w	20	33	their	-PRON-	PRP$
cord-288020-vhtr3l0w	20	34	hospital	hospital	NN
cord-288020-vhtr3l0w	20	35	stay	stay	NN
cord-288020-vhtr3l0w	20	36	.	.	.
cord-288020-vhtr3l0w	21	1	The	the	DT
cord-288020-vhtr3l0w	21	2	timing	timing	NN
cord-288020-vhtr3l0w	21	3	of	of	IN
cord-288020-vhtr3l0w	21	4	the	the	DT
cord-288020-vhtr3l0w	21	5	risk	risk	NN
cord-288020-vhtr3l0w	21	6	stratification	stratification	NN
cord-288020-vhtr3l0w	21	7	process	process	NN
cord-288020-vhtr3l0w	21	8	in	in	IN
cord-288020-vhtr3l0w	21	9	the	the	DT
cord-288020-vhtr3l0w	21	10	course	course	NN
cord-288020-vhtr3l0w	21	11	of	of	IN
cord-288020-vhtr3l0w	21	12	the	the	DT
cord-288020-vhtr3l0w	21	13	disease	disease	NN
cord-288020-vhtr3l0w	21	14	for	for	IN
cord-288020-vhtr3l0w	21	15	each	each	DT
cord-288020-vhtr3l0w	21	16	individual	individual	JJ
cord-288020-vhtr3l0w	21	17	patient	patient	NN
cord-288020-vhtr3l0w	21	18	is	be	VBZ
cord-288020-vhtr3l0w	21	19	critical	critical	JJ
cord-288020-vhtr3l0w	21	20	.	.	.
cord-288020-vhtr3l0w	22	1	In	in	IN
cord-288020-vhtr3l0w	22	2	the	the	DT
cord-288020-vhtr3l0w	22	3	present	present	JJ
cord-288020-vhtr3l0w	22	4	study	study	NN
cord-288020-vhtr3l0w	22	5	,	,	,
cord-288020-vhtr3l0w	22	6	the	the	DT
cord-288020-vhtr3l0w	22	7	blood	blood	NN
cord-288020-vhtr3l0w	22	8	sampling	sampling	NN
cord-288020-vhtr3l0w	22	9	and	and	CC
cord-288020-vhtr3l0w	22	10	assessment	assessment	NN
cord-288020-vhtr3l0w	22	11	of	of	IN
cord-288020-vhtr3l0w	22	12	risk	risk	NN
cord-288020-vhtr3l0w	22	13	factors	factor	NNS
cord-288020-vhtr3l0w	22	14	used	use	VBN
cord-288020-vhtr3l0w	22	15	to	to	TO
cord-288020-vhtr3l0w	22	16	determine	determine	VB
cord-288020-vhtr3l0w	22	17	the	the	DT
cord-288020-vhtr3l0w	22	18	HNC	HNC	NNP
cord-288020-vhtr3l0w	22	19	-	-	HYPH
cord-288020-vhtr3l0w	22	20	LL	LL	NNP
cord-288020-vhtr3l0w	22	21	risk	risk	NN
cord-288020-vhtr3l0w	22	22	score	score	NN
cord-288020-vhtr3l0w	22	23	were	be	VBD
cord-288020-vhtr3l0w	22	24	performed	perform	VBN
cord-288020-vhtr3l0w	22	25	on	on	IN
cord-288020-vhtr3l0w	22	26	the	the	DT
cord-288020-vhtr3l0w	22	27	day	day	NN
cord-288020-vhtr3l0w	22	28	of	of	IN
cord-288020-vhtr3l0w	22	29	hospital	hospital	NN
cord-288020-vhtr3l0w	22	30	admission	admission	NN
cord-288020-vhtr3l0w	22	31	.	.	.
cord-288020-vhtr3l0w	23	1	However	however	RB
cord-288020-vhtr3l0w	23	2	,	,	,
cord-288020-vhtr3l0w	23	3	patients	patient	NNS
cord-288020-vhtr3l0w	23	4	likely	likely	RB
cord-288020-vhtr3l0w	23	5	presented	present	VBN
cord-288020-vhtr3l0w	23	6	to	to	IN
cord-288020-vhtr3l0w	23	7	the	the	DT
cord-288020-vhtr3l0w	23	8	hospital	hospital	NN
cord-288020-vhtr3l0w	23	9	at	at	IN
cord-288020-vhtr3l0w	23	10	different	different	JJ
cord-288020-vhtr3l0w	23	11	stages	stage	NNS
cord-288020-vhtr3l0w	23	12	of	of	IN
cord-288020-vhtr3l0w	23	13	their	-PRON-	PRP$
cord-288020-vhtr3l0w	23	14	disease	disease	NN
cord-288020-vhtr3l0w	23	15	.	.	.
cord-288020-vhtr3l0w	24	1	The	the	DT
cord-288020-vhtr3l0w	24	2	delay	delay	NN
cord-288020-vhtr3l0w	24	3	between	between	IN
cord-288020-vhtr3l0w	24	4	the	the	DT
cord-288020-vhtr3l0w	24	5	onset	onset	NN
cord-288020-vhtr3l0w	24	6	of	of	IN
cord-288020-vhtr3l0w	24	7	symptoms	symptom	NNS
cord-288020-vhtr3l0w	24	8	and	and	CC
cord-288020-vhtr3l0w	24	9	the	the	DT
cord-288020-vhtr3l0w	24	10	medical	medical	JJ
cord-288020-vhtr3l0w	24	11	examination	examination	NN
cord-288020-vhtr3l0w	24	12	is	be	VBZ
cord-288020-vhtr3l0w	24	13	a	a	DT
cord-288020-vhtr3l0w	24	14	key	key	JJ
cord-288020-vhtr3l0w	24	15	factor	factor	NN
cord-288020-vhtr3l0w	24	16	to	to	TO
cord-288020-vhtr3l0w	24	17	consider	consider	VB
cord-288020-vhtr3l0w	24	18	as	as	IN
cord-288020-vhtr3l0w	24	19	it	-PRON-	PRP
cord-288020-vhtr3l0w	24	20	provides	provide	VBZ
cord-288020-vhtr3l0w	24	21	an	an	DT
cord-288020-vhtr3l0w	24	22	estimation	estimation	NN
cord-288020-vhtr3l0w	24	23	of	of	IN
cord-288020-vhtr3l0w	24	24	the	the	DT
cord-288020-vhtr3l0w	24	25	stage	stage	NN
cord-288020-vhtr3l0w	24	26	of	of	IN
cord-288020-vhtr3l0w	24	27	disease	disease	NN
cord-288020-vhtr3l0w	24	28	,	,	,
cord-288020-vhtr3l0w	24	29	which	which	WDT
cord-288020-vhtr3l0w	24	30	was	be	VBD
cord-288020-vhtr3l0w	24	31	not	not	RB
cord-288020-vhtr3l0w	24	32	taken	take	VBN
cord-288020-vhtr3l0w	24	33	into	into	IN
cord-288020-vhtr3l0w	24	34	account	account	NN
cord-288020-vhtr3l0w	24	35	in	in	IN
cord-288020-vhtr3l0w	24	36	the	the	DT
cord-288020-vhtr3l0w	24	37	study	study	NN
cord-288020-vhtr3l0w	24	38	by	by	IN
cord-288020-vhtr3l0w	24	39	Xiao	Xiao	NNP
cord-288020-vhtr3l0w	24	40	et	et	NNP
cord-288020-vhtr3l0w	24	41	al	al	NNP
cord-288020-vhtr3l0w	24	42	.	.	.
cord-288020-vhtr3l0w	25	1	[	[	-LRB-
cord-288020-vhtr3l0w	25	2	1	1	CD
cord-288020-vhtr3l0w	25	3	]	]	-RRB-
cord-288020-vhtr3l0w	26	1	Another	another	DT
cord-288020-vhtr3l0w	26	2	limitation	limitation	NN
cord-288020-vhtr3l0w	26	3	of	of	IN
cord-288020-vhtr3l0w	26	4	the	the	DT
cord-288020-vhtr3l0w	26	5	HNC	HNC	NNP
cord-288020-vhtr3l0w	26	6	-	-	HYPH
cord-288020-vhtr3l0w	26	7	LL	LL	NNP
cord-288020-vhtr3l0w	26	8	,	,	,
cord-288020-vhtr3l0w	26	9	CURB-65	CURB-65	NNP
cord-288020-vhtr3l0w	26	10	or	or	CC
cord-288020-vhtr3l0w	26	11	MuLBSTA	MuLBSTA	NNP
cord-288020-vhtr3l0w	26	12	scores	score	NNS
cord-288020-vhtr3l0w	26	13	is	be	VBZ
cord-288020-vhtr3l0w	26	14	that	that	IN
cord-288020-vhtr3l0w	26	15	they	-PRON-	PRP
cord-288020-vhtr3l0w	26	16	require	require	VBP
cord-288020-vhtr3l0w	26	17	blood	blood	NN
cord-288020-vhtr3l0w	26	18	sampling	sampling	NN
cord-288020-vhtr3l0w	26	19	[	[	-LRB-
cord-288020-vhtr3l0w	26	20	2	2	CD
cord-288020-vhtr3l0w	26	21	,	,	,
cord-288020-vhtr3l0w	26	22	3	3	CD
cord-288020-vhtr3l0w	26	23	]	]	-RRB-
cord-288020-vhtr3l0w	26	24	,	,	,
cord-288020-vhtr3l0w	26	25	which	which	WDT
cord-288020-vhtr3l0w	26	26	limit	limit	VBP
cord-288020-vhtr3l0w	26	27	their	-PRON-	PRP$
cord-288020-vhtr3l0w	26	28	utilisation	utilisation	NN
cord-288020-vhtr3l0w	26	29	for	for	IN
cord-288020-vhtr3l0w	26	30	non	non	JJ
cord-288020-vhtr3l0w	26	31	-	-	JJ
cord-288020-vhtr3l0w	26	32	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	26	33	patients	patient	NNS
cord-288020-vhtr3l0w	26	34	with	with	IN
cord-288020-vhtr3l0w	26	35	mild	mild	JJ
cord-288020-vhtr3l0w	26	36	or	or	CC
cord-288020-vhtr3l0w	26	37	moderate	moderate	JJ
cord-288020-vhtr3l0w	26	38	symptoms	symptom	NNS
cord-288020-vhtr3l0w	26	39	.	.	.
cord-288020-vhtr3l0w	27	1	A	a	DT
cord-288020-vhtr3l0w	27	2	recent	recent	JJ
cord-288020-vhtr3l0w	27	3	study	study	NN
cord-288020-vhtr3l0w	27	4	reported	report	VBD
cord-288020-vhtr3l0w	27	5	that	that	IN
cord-288020-vhtr3l0w	27	6	21	21	CD
cord-288020-vhtr3l0w	27	7	%	%	NN
cord-288020-vhtr3l0w	27	8	of	of	IN
cord-288020-vhtr3l0w	27	9	COVID-19	covid-19	JJ
cord-288020-vhtr3l0w	27	10	patients	patient	NNS
cord-288020-vhtr3l0w	27	11	initially	initially	RB
cord-288020-vhtr3l0w	27	12	considered	consider	VBN
cord-288020-vhtr3l0w	27	13	to	to	TO
cord-288020-vhtr3l0w	27	14	be	be	VB
cord-288020-vhtr3l0w	27	15	at	at	IN
cord-288020-vhtr3l0w	27	16	low	low	JJ
cord-288020-vhtr3l0w	27	17	risk	risk	NN
cord-288020-vhtr3l0w	27	18	,	,	,
cord-288020-vhtr3l0w	27	19	in	in	IN
cord-288020-vhtr3l0w	27	20	fact	fact	NN
cord-288020-vhtr3l0w	27	21	,	,	,
cord-288020-vhtr3l0w	27	22	had	have	VBD
cord-288020-vhtr3l0w	27	23	poor	poor	JJ
cord-288020-vhtr3l0w	27	24	outcomes	outcome	NNS
cord-288020-vhtr3l0w	27	25	[	[	-LRB-
cord-288020-vhtr3l0w	27	26	4	4	CD
cord-288020-vhtr3l0w	27	27	]	]	-RRB-
cord-288020-vhtr3l0w	27	28	.	.	.
cord-288020-vhtr3l0w	28	1	One	one	CD
cord-288020-vhtr3l0w	28	2	potential	potential	JJ
cord-288020-vhtr3l0w	28	3	solution	solution	NN
cord-288020-vhtr3l0w	28	4	to	to	TO
cord-288020-vhtr3l0w	28	5	optimize	optimize	VB
cord-288020-vhtr3l0w	28	6	the	the	DT
cord-288020-vhtr3l0w	28	7	risk	risk	NN
cord-288020-vhtr3l0w	28	8	stratification	stratification	NN
cord-288020-vhtr3l0w	28	9	process	process	NN
cord-288020-vhtr3l0w	28	10	would	would	MD
cord-288020-vhtr3l0w	28	11	be	be	VB
cord-288020-vhtr3l0w	28	12	to	to	TO
cord-288020-vhtr3l0w	28	13	use	use	VB
cord-288020-vhtr3l0w	28	14	different	different	JJ
cord-288020-vhtr3l0w	28	15	scores	score	NNS
cord-288020-vhtr3l0w	28	16	adapted	adapt	VBN
cord-288020-vhtr3l0w	28	17	to	to	IN
cord-288020-vhtr3l0w	28	18	the	the	DT
cord-288020-vhtr3l0w	28	19	setting	setting	NN
cord-288020-vhtr3l0w	28	20	and	and	CC
cord-288020-vhtr3l0w	28	21	the	the	DT
cord-288020-vhtr3l0w	28	22	timing	timing	NN
cord-288020-vhtr3l0w	28	23	of	of	IN
cord-288020-vhtr3l0w	28	24	the	the	DT
cord-288020-vhtr3l0w	28	25	patient	patient	JJ
cord-288020-vhtr3l0w	28	26	presentation	presentation	NN
cord-288020-vhtr3l0w	28	27	.	.	.
cord-288020-vhtr3l0w	29	1	Hence	hence	RB
cord-288020-vhtr3l0w	29	2	,	,	,
cord-288020-vhtr3l0w	29	3	in	in	IN
cord-288020-vhtr3l0w	29	4	an	an	DT
cord-288020-vhtr3l0w	29	5	outpatient	outpatient	NN
cord-288020-vhtr3l0w	29	6	setting	setting	NN
cord-288020-vhtr3l0w	29	7	,	,	,
cord-288020-vhtr3l0w	29	8	where	where	WRB
cord-288020-vhtr3l0w	29	9	patients	patient	NNS
cord-288020-vhtr3l0w	29	10	would	would	MD
cord-288020-vhtr3l0w	29	11	generally	generally	RB
cord-288020-vhtr3l0w	29	12	be	be	VB
cord-288020-vhtr3l0w	29	13	at	at	IN
cord-288020-vhtr3l0w	29	14	an	an	DT
cord-288020-vhtr3l0w	29	15	earlier	early	JJR
cord-288020-vhtr3l0w	29	16	stage	stage	NN
cord-288020-vhtr3l0w	29	17	of	of	IN
cord-288020-vhtr3l0w	29	18	the	the	DT
cord-288020-vhtr3l0w	29	19	disease	disease	NN
cord-288020-vhtr3l0w	29	20	,	,	,
cord-288020-vhtr3l0w	29	21	clinical	clinical	JJ
cord-288020-vhtr3l0w	29	22	scores	score	NNS
cord-288020-vhtr3l0w	29	23	such	such	JJ
cord-288020-vhtr3l0w	29	24	as	as	IN
cord-288020-vhtr3l0w	29	25	the	the	DT
cord-288020-vhtr3l0w	29	26	CRB-65	CRB-65	NNP
cord-288020-vhtr3l0w	29	27	(	(	-LRB-
cord-288020-vhtr3l0w	29	28	CURB-65	curb-65	NN
cord-288020-vhtr3l0w	29	29	without	without	IN
cord-288020-vhtr3l0w	29	30	urea	urea	NN
cord-288020-vhtr3l0w	29	31	)	)	-RRB-
cord-288020-vhtr3l0w	29	32	or	or	CC
cord-288020-vhtr3l0w	29	33	the	the	DT
cord-288020-vhtr3l0w	29	34	qSOFA	qsofa	JJ
cord-288020-vhtr3l0w	29	35	score	score	NN
cord-288020-vhtr3l0w	29	36	(	(	-LRB-
cord-288020-vhtr3l0w	29	37	quick	quick	JJ
cord-288020-vhtr3l0w	29	38	sepsis	sepsis	NN
cord-288020-vhtr3l0w	29	39	-	-	HYPH
cord-288020-vhtr3l0w	29	40	related	relate	VBN
cord-288020-vhtr3l0w	29	41	organ	organ	NN
cord-288020-vhtr3l0w	29	42	failure	failure	NN
cord-288020-vhtr3l0w	29	43	assessment	assessment	NN
cord-288020-vhtr3l0w	29	44	)	)	-RRB-
cord-288020-vhtr3l0w	29	45	could	could	MD
cord-288020-vhtr3l0w	29	46	be	be	VB
cord-288020-vhtr3l0w	29	47	considered	consider	VBN
cord-288020-vhtr3l0w	29	48	[	[	-LRB-
cord-288020-vhtr3l0w	29	49	5	5	CD
cord-288020-vhtr3l0w	29	50	]	]	-RRB-
cord-288020-vhtr3l0w	29	51	.	.	.
cord-288020-vhtr3l0w	30	1	Given	give	VBN
cord-288020-vhtr3l0w	30	2	that	that	IN
cord-288020-vhtr3l0w	30	3	these	these	DT
cord-288020-vhtr3l0w	30	4	scores	score	NNS
cord-288020-vhtr3l0w	30	5	are	be	VBP
cord-288020-vhtr3l0w	30	6	usually	usually	RB
cord-288020-vhtr3l0w	30	7	utilized	utilize	VBN
cord-288020-vhtr3l0w	30	8	in	in	IN
cord-288020-vhtr3l0w	30	9	the	the	DT
cord-288020-vhtr3l0w	30	10	context	context	NN
cord-288020-vhtr3l0w	30	11	of	of	IN
cord-288020-vhtr3l0w	30	12	severe	severe	JJ
cord-288020-vhtr3l0w	30	13	disease	disease	NN
cord-288020-vhtr3l0w	30	14	,	,	,
cord-288020-vhtr3l0w	30	15	lower	lower	RBR
cord-288020-vhtr3l0w	30	16	cut	cut	VB
cord-288020-vhtr3l0w	30	17	-	-	HYPH
cord-288020-vhtr3l0w	30	18	off	off	RP
cord-288020-vhtr3l0w	30	19	values	value	NNS
cord-288020-vhtr3l0w	30	20	should	should	MD
cord-288020-vhtr3l0w	30	21	likely	likely	RB
cord-288020-vhtr3l0w	30	22	be	be	VB
cord-288020-vhtr3l0w	30	23	applied	apply	VBN
cord-288020-vhtr3l0w	30	24	to	to	TO
cord-288020-vhtr3l0w	30	25	improve	improve	VB
cord-288020-vhtr3l0w	30	26	their	-PRON-	PRP$
cord-288020-vhtr3l0w	30	27	sensitivity	sensitivity	NN
cord-288020-vhtr3l0w	30	28	to	to	TO
cord-288020-vhtr3l0w	30	29	identify	identify	VB
cord-288020-vhtr3l0w	30	30	the	the	DT
cord-288020-vhtr3l0w	30	31	patients	patient	NNS
cord-288020-vhtr3l0w	30	32	being	be	VBG
cord-288020-vhtr3l0w	30	33	at	at	IN
cord-288020-vhtr3l0w	30	34	risk	risk	NN
cord-288020-vhtr3l0w	30	35	of	of	IN
cord-288020-vhtr3l0w	30	36	hospitalization	hospitalization	NN
cord-288020-vhtr3l0w	30	37	and	and	CC
cord-288020-vhtr3l0w	30	38	complications	complication	NNS
cord-288020-vhtr3l0w	30	39	(	(	-LRB-
cord-288020-vhtr3l0w	30	40	Fig	fig	NN
cord-288020-vhtr3l0w	30	41	.	.	NNP
cord-288020-vhtr3l0w	30	42	1	1	CD
cord-288020-vhtr3l0w	30	43	)	)	-RRB-
cord-288020-vhtr3l0w	30	44	.	.	.
cord-288020-vhtr3l0w	31	1	Another	another	DT
cord-288020-vhtr3l0w	31	2	way	way	NN
cord-288020-vhtr3l0w	31	3	to	to	TO
cord-288020-vhtr3l0w	31	4	potentially	potentially	RB
cord-288020-vhtr3l0w	31	5	improve	improve	VB
cord-288020-vhtr3l0w	31	6	the	the	DT
cord-288020-vhtr3l0w	31	7	performance	performance	NN
cord-288020-vhtr3l0w	31	8	of	of	IN
cord-288020-vhtr3l0w	31	9	those	those	DT
cord-288020-vhtr3l0w	31	10	risk	risk	NN
cord-288020-vhtr3l0w	31	11	scores	score	NNS
cord-288020-vhtr3l0w	31	12	in	in	IN
cord-288020-vhtr3l0w	31	13	the	the	DT
cord-288020-vhtr3l0w	31	14	management	management	NN
cord-288020-vhtr3l0w	31	15	of	of	IN
cord-288020-vhtr3l0w	31	16	COVD-19	COVD-19	NNP
cord-288020-vhtr3l0w	31	17	would	would	MD
cord-288020-vhtr3l0w	31	18	be	be	VB
cord-288020-vhtr3l0w	31	19	to	to	TO
cord-288020-vhtr3l0w	31	20	include	include	VB
cord-288020-vhtr3l0w	31	21	clinical	clinical	JJ
cord-288020-vhtr3l0w	31	22	factors	factor	NNS
cord-288020-vhtr3l0w	31	23	proven	prove	VBN
cord-288020-vhtr3l0w	31	24	relevant	relevant	JJ
cord-288020-vhtr3l0w	31	25	to	to	IN
cord-288020-vhtr3l0w	31	26	affected	affected	JJ
cord-288020-vhtr3l0w	31	27	patients	patient	NNS
cord-288020-vhtr3l0w	31	28	(	(	-LRB-
cord-288020-vhtr3l0w	31	29	Fig	Fig	NNP
cord-288020-vhtr3l0w	31	30	.	.	.
cord-288020-vhtr3l0w	31	31	1	1	CD
cord-288020-vhtr3l0w	31	32	)	)	-RRB-
cord-288020-vhtr3l0w	31	33	.	.	.
cord-288020-vhtr3l0w	32	1	Indeed	indeed	RB
cord-288020-vhtr3l0w	32	2	,	,	,
cord-288020-vhtr3l0w	32	3	a	a	DT
cord-288020-vhtr3l0w	32	4	striking	striking	JJ
cord-288020-vhtr3l0w	32	5	difference	difference	NN
cord-288020-vhtr3l0w	32	6	of	of	IN
cord-288020-vhtr3l0w	32	7	SARS	SARS	NNP
cord-288020-vhtr3l0w	32	8	-	-	HYPH
cord-288020-vhtr3l0w	32	9	COV-2	COV-2	NNP
cord-288020-vhtr3l0w	32	10	infection	infection	NN
cord-288020-vhtr3l0w	32	11	compared	compare	VBN
cord-288020-vhtr3l0w	32	12	to	to	IN
cord-288020-vhtr3l0w	32	13	other	other	JJ
cord-288020-vhtr3l0w	32	14	respiratory	respiratory	JJ
cord-288020-vhtr3l0w	32	15	viral	viral	JJ
cord-288020-vhtr3l0w	32	16	infections	infection	NNS
cord-288020-vhtr3l0w	32	17	is	be	VBZ
cord-288020-vhtr3l0w	32	18	that	that	IN
cord-288020-vhtr3l0w	32	19	cardiometabolic	cardiometabolic	JJ
cord-288020-vhtr3l0w	32	20	comorbidities	comorbiditie	NNS
cord-288020-vhtr3l0w	32	21	have	have	VBP
cord-288020-vhtr3l0w	32	22	been	be	VBN
cord-288020-vhtr3l0w	32	23	over	over	RB
cord-288020-vhtr3l0w	32	24	-	-	HYPH
cord-288020-vhtr3l0w	32	25	represented	represent	VBN
cord-288020-vhtr3l0w	32	26	in	in	IN
cord-288020-vhtr3l0w	32	27	patients	patient	NNS
cord-288020-vhtr3l0w	32	28	presenting	present	VBG
cord-288020-vhtr3l0w	32	29	complications	complication	NNS
cord-288020-vhtr3l0w	32	30	,	,	,
cord-288020-vhtr3l0w	32	31	while	while	IN
cord-288020-vhtr3l0w	32	32	other	other	JJ
cord-288020-vhtr3l0w	32	33	pulmonary	pulmonary	JJ
cord-288020-vhtr3l0w	32	34	comorbidities	comorbiditie	NNS
cord-288020-vhtr3l0w	32	35	that	that	WDT
cord-288020-vhtr3l0w	32	36	are	be	VBP
cord-288020-vhtr3l0w	32	37	usually	usually	RB
cord-288020-vhtr3l0w	32	38	more	more	RBR
cord-288020-vhtr3l0w	32	39	prevalent	prevalent	JJ
cord-288020-vhtr3l0w	32	40	with	with	IN
cord-288020-vhtr3l0w	32	41	respiratory	respiratory	JJ
cord-288020-vhtr3l0w	32	42	viral	viral	JJ
cord-288020-vhtr3l0w	32	43	infections	infection	NNS
cord-288020-vhtr3l0w	32	44	such	such	JJ
cord-288020-vhtr3l0w	32	45	as	as	IN
cord-288020-vhtr3l0w	32	46	asthma	asthma	NN
cord-288020-vhtr3l0w	32	47	,	,	,
cord-288020-vhtr3l0w	32	48	smoking	smoking	NN
cord-288020-vhtr3l0w	32	49	,	,	,
cord-288020-vhtr3l0w	32	50	or	or	CC
cord-288020-vhtr3l0w	32	51	COPD	COPD	NNP
cord-288020-vhtr3l0w	32	52	are	be	VBP
cord-288020-vhtr3l0w	32	53	under	under	RB
cord-288020-vhtr3l0w	32	54	-	-	HYPH
cord-288020-vhtr3l0w	32	55	represented	represent	VBN
cord-288020-vhtr3l0w	32	56	.	.	.
cord-288020-vhtr3l0w	33	1	In	in	IN
cord-288020-vhtr3l0w	33	2	the	the	DT
cord-288020-vhtr3l0w	33	3	study	study	NN
cord-288020-vhtr3l0w	33	4	of	of	IN
cord-288020-vhtr3l0w	33	5	Xiao	Xiao	NNP
cord-288020-vhtr3l0w	33	6	et	et	NNP
cord-288020-vhtr3l0w	33	7	al	al	NNP
cord-288020-vhtr3l0w	33	8	.	.	.
cord-288020-vhtr3l0w	34	1	hypertension	hypertension	NN
cord-288020-vhtr3l0w	34	2	was	be	VBD
cord-288020-vhtr3l0w	34	3	included	include	VBN
cord-288020-vhtr3l0w	34	4	into	into	IN
cord-288020-vhtr3l0w	34	5	the	the	DT
cord-288020-vhtr3l0w	34	6	risk	risk	NN
cord-288020-vhtr3l0w	34	7	score	score	NN
cord-288020-vhtr3l0w	34	8	but	but	CC
cord-288020-vhtr3l0w	34	9	not	not	RB
cord-288020-vhtr3l0w	34	10	obesity	obesity	NN
cord-288020-vhtr3l0w	34	11	or	or	CC
cord-288020-vhtr3l0w	34	12	diabetes	diabetes	NN
cord-288020-vhtr3l0w	34	13	[	[	-LRB-
cord-288020-vhtr3l0w	34	14	1	1	CD
cord-288020-vhtr3l0w	34	15	]	]	-RRB-
cord-288020-vhtr3l0w	34	16	,	,	,
cord-288020-vhtr3l0w	34	17	which	which	WDT
cord-288020-vhtr3l0w	34	18	have	have	VBP
cord-288020-vhtr3l0w	34	19	previously	previously	RB
cord-288020-vhtr3l0w	34	20	been	be	VBN
cord-288020-vhtr3l0w	34	21	shown	show	VBN
cord-288020-vhtr3l0w	34	22	to	to	TO
cord-288020-vhtr3l0w	34	23	be	be	VB
cord-288020-vhtr3l0w	34	24	strongly	strongly	RB
cord-288020-vhtr3l0w	34	25	associated	associate	VBN
cord-288020-vhtr3l0w	34	26	with	with	IN
cord-288020-vhtr3l0w	34	27	poor	poor	JJ
cord-288020-vhtr3l0w	34	28	outcomes	outcome	NNS
cord-288020-vhtr3l0w	34	29	in	in	IN
cord-288020-vhtr3l0w	34	30	patients	patient	NNS
cord-288020-vhtr3l0w	34	31	with	with	IN
cord-288020-vhtr3l0w	34	32	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	34	33	[	[	-LRB-
cord-288020-vhtr3l0w	34	34	6	6	CD
cord-288020-vhtr3l0w	34	35	]	]	-RRB-
cord-288020-vhtr3l0w	34	36	.	.	.
cord-288020-vhtr3l0w	35	1	The	the	DT
cord-288020-vhtr3l0w	35	2	set	set	NN
cord-288020-vhtr3l0w	35	3	of	of	IN
cord-288020-vhtr3l0w	35	4	variables	variable	NNS
cord-288020-vhtr3l0w	35	5	included	include	VBN
cord-288020-vhtr3l0w	35	6	in	in	IN
cord-288020-vhtr3l0w	35	7	the	the	DT
cord-288020-vhtr3l0w	35	8	final	final	JJ
cord-288020-vhtr3l0w	35	9	score	score	NN
cord-288020-vhtr3l0w	35	10	by	by	IN
cord-288020-vhtr3l0w	35	11	Xiao	Xiao	NNP
cord-288020-vhtr3l0w	35	12	et	et	NNP
cord-288020-vhtr3l0w	35	13	al	al	NNP
cord-288020-vhtr3l0w	35	14	.	.	NNP
cord-288020-vhtr3l0w	35	15	presents	present	VBZ
cord-288020-vhtr3l0w	35	16	several	several	JJ
cord-288020-vhtr3l0w	35	17	limitations	limitation	NNS
cord-288020-vhtr3l0w	35	18	and	and	CC
cord-288020-vhtr3l0w	35	19	pitfalls	pitfall	NNS
cord-288020-vhtr3l0w	35	20	that	that	WDT
cord-288020-vhtr3l0w	35	21	warrant	warrant	VBP
cord-288020-vhtr3l0w	35	22	discussion	discussion	NN
cord-288020-vhtr3l0w	35	23	.	.	.
cord-288020-vhtr3l0w	36	1	First	first	RB
cord-288020-vhtr3l0w	36	2	,	,	,
cord-288020-vhtr3l0w	36	3	the	the	DT
cord-288020-vhtr3l0w	36	4	authors	author	NNS
cord-288020-vhtr3l0w	36	5	included	include	VBD
cord-288020-vhtr3l0w	36	6	two	two	CD
cord-288020-vhtr3l0w	36	7	markers	marker	NNS
cord-288020-vhtr3l0w	36	8	of	of	IN
cord-288020-vhtr3l0w	36	9	white	white	JJ
cord-288020-vhtr3l0w	36	10	blood	blood	NN
cord-288020-vhtr3l0w	36	11	cells	cell	NNS
cord-288020-vhtr3l0w	36	12	,	,	,
cord-288020-vhtr3l0w	36	13	which	which	WDT
cord-288020-vhtr3l0w	36	14	may	may	MD
cord-288020-vhtr3l0w	36	15	,	,	,
cord-288020-vhtr3l0w	36	16	to	to	IN
cord-288020-vhtr3l0w	36	17	some	some	DT
cord-288020-vhtr3l0w	36	18	extent	extent	NN
cord-288020-vhtr3l0w	36	19	be	be	VB
cord-288020-vhtr3l0w	36	20	redundant	redundant	JJ
cord-288020-vhtr3l0w	36	21	.	.	.
cord-288020-vhtr3l0w	37	1	It	-PRON-	PRP
cord-288020-vhtr3l0w	37	2	also	also	RB
cord-288020-vhtr3l0w	37	3	likely	likely	RB
cord-288020-vhtr3l0w	37	4	suggests	suggest	VBZ
cord-288020-vhtr3l0w	37	5	that	that	IN
cord-288020-vhtr3l0w	37	6	patients	patient	NNS
cord-288020-vhtr3l0w	37	7	had	have	VBD
cord-288020-vhtr3l0w	37	8	been	be	VBN
cord-288020-vhtr3l0w	37	9	infected	infect	VBN
cord-288020-vhtr3l0w	37	10	for	for	IN
cord-288020-vhtr3l0w	37	11	several	several	JJ
cord-288020-vhtr3l0w	37	12	days	day	NNS
cord-288020-vhtr3l0w	37	13	and	and	CC
cord-288020-vhtr3l0w	37	14	had	have	VBD
cord-288020-vhtr3l0w	37	15	developed	develop	VBN
cord-288020-vhtr3l0w	37	16	a	a	DT
cord-288020-vhtr3l0w	37	17	bacterial	bacterial	JJ
cord-288020-vhtr3l0w	37	18	infection	infection	NN
cord-288020-vhtr3l0w	37	19	rendering	render	VBG
cord-288020-vhtr3l0w	37	20	the	the	DT
cord-288020-vhtr3l0w	37	21	neutrophil	neutrophil	NN
cord-288020-vhtr3l0w	37	22	count	count	NN
cord-288020-vhtr3l0w	37	23	significant	significant	JJ
cord-288020-vhtr3l0w	37	24	.	.	.
cord-288020-vhtr3l0w	38	1	The	the	DT
cord-288020-vhtr3l0w	38	2	complications	complication	NNS
cord-288020-vhtr3l0w	38	3	and	and	CC
cord-288020-vhtr3l0w	38	4	adverse	adverse	JJ
cord-288020-vhtr3l0w	38	5	events	event	NNS
cord-288020-vhtr3l0w	38	6	associated	associate	VBN
cord-288020-vhtr3l0w	38	7	with	with	IN
cord-288020-vhtr3l0w	38	8	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	38	9	are	be	VBP
cord-288020-vhtr3l0w	38	10	 	 	_SP
cord-288020-vhtr3l0w	38	11	EBioMedicine	EBioMedicine	NNP
cord-288020-vhtr3l0w	38	12	journal	journal	NN
cord-288020-vhtr3l0w	38	13	homepage	homepage	NN
cord-288020-vhtr3l0w	38	14	:	:	:
cord-288020-vhtr3l0w	38	15	www.elsevier.com/locate/ebiom	www.elsevier.com/locate/ebiom	NNP
cord-288020-vhtr3l0w	38	16	generally	generally	RB
cord-288020-vhtr3l0w	38	17	related	relate	VBN
cord-288020-vhtr3l0w	38	18	to	to	IN
cord-288020-vhtr3l0w	38	19	inflammation	inflammation	NN
cord-288020-vhtr3l0w	38	20	and	and	CC
cord-288020-vhtr3l0w	38	21	the	the	DT
cord-288020-vhtr3l0w	38	22	ensuing	ensue	VBG
cord-288020-vhtr3l0w	38	23	"	"	``
cord-288020-vhtr3l0w	38	24	cytokine	cytokine	NN
cord-288020-vhtr3l0w	38	25	storm	storm	NN
cord-288020-vhtr3l0w	38	26	"	"	''
cord-288020-vhtr3l0w	38	27	,	,	,
cord-288020-vhtr3l0w	38	28	thromboembolism	thromboembolism	NN
cord-288020-vhtr3l0w	38	29	,	,	,
cord-288020-vhtr3l0w	38	30	and	and	CC
cord-288020-vhtr3l0w	38	31	cardiac	cardiac	JJ
cord-288020-vhtr3l0w	38	32	damage	damage	NN
cord-288020-vhtr3l0w	38	33	.	.	.
cord-288020-vhtr3l0w	39	1	Previous	previous	JJ
cord-288020-vhtr3l0w	39	2	studies	study	NNS
cord-288020-vhtr3l0w	39	3	have	have	VBP
cord-288020-vhtr3l0w	39	4	reported	report	VBN
cord-288020-vhtr3l0w	39	5	that	that	IN
cord-288020-vhtr3l0w	39	6	an	an	DT
cord-288020-vhtr3l0w	39	7	important	important	JJ
cord-288020-vhtr3l0w	39	8	proportion	proportion	NN
cord-288020-vhtr3l0w	39	9	(	(	-LRB-
cord-288020-vhtr3l0w	39	10	>	>	NFP
cord-288020-vhtr3l0w	39	11	20	20	CD
cord-288020-vhtr3l0w	39	12	%	%	NN
cord-288020-vhtr3l0w	39	13	)	)	-RRB-
cord-288020-vhtr3l0w	39	14	of	of	IN
cord-288020-vhtr3l0w	39	15	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	39	16	patients	patient	NNS
cord-288020-vhtr3l0w	39	17	with	with	IN
cord-288020-vhtr3l0w	39	18	COVID-19	covid-19	DT
cord-288020-vhtr3l0w	39	19	present	present	JJ
cord-288020-vhtr3l0w	39	20	with	with	IN
cord-288020-vhtr3l0w	39	21	a	a	DT
cord-288020-vhtr3l0w	39	22	marked	marked	JJ
cord-288020-vhtr3l0w	39	23	elevation	elevation	NN
cord-288020-vhtr3l0w	39	24	of	of	IN
cord-288020-vhtr3l0w	39	25	circulating	circulate	VBG
cord-288020-vhtr3l0w	39	26	biomarkers	biomarker	NNS
cord-288020-vhtr3l0w	39	27	of	of	IN
cord-288020-vhtr3l0w	39	28	inflammation	inflammation	NN
cord-288020-vhtr3l0w	39	29	(	(	-LRB-
cord-288020-vhtr3l0w	39	30	CRP	CRP	NNP
cord-288020-vhtr3l0w	39	31	,	,	,
cord-288020-vhtr3l0w	39	32	Ferritin	Ferritin	NNP
cord-288020-vhtr3l0w	39	33	)	)	-RRB-
cord-288020-vhtr3l0w	39	34	,	,	,
cord-288020-vhtr3l0w	39	35	cardiovascular	cardiovascular	JJ
cord-288020-vhtr3l0w	39	36	damage	damage	NN
cord-288020-vhtr3l0w	39	37	(	(	-LRB-
cord-288020-vhtr3l0w	39	38	Troponin	Troponin	NNP
cord-288020-vhtr3l0w	39	39	)	)	-RRB-
cord-288020-vhtr3l0w	39	40	and	and	CC
cord-288020-vhtr3l0w	39	41	thrombo	thrombo	NN
cord-288020-vhtr3l0w	39	42	-	-	HYPH
cord-288020-vhtr3l0w	39	43	embolism	embolism	NN
cord-288020-vhtr3l0w	39	44	(	(	-LRB-
cord-288020-vhtr3l0w	39	45	D	D	NNP
cord-288020-vhtr3l0w	39	46	-	-	HYPH
cord-288020-vhtr3l0w	39	47	Dimers	Dimers	NNPS
cord-288020-vhtr3l0w	39	48	)	)	-RRB-
cord-288020-vhtr3l0w	39	49	,	,	,
cord-288020-vhtr3l0w	39	50	identifying	identify	VBG
cord-288020-vhtr3l0w	39	51	subgroups	subgroup	NNS
cord-288020-vhtr3l0w	39	52	of	of	IN
cord-288020-vhtr3l0w	39	53	patients	patient	NNS
cord-288020-vhtr3l0w	39	54	at	at	IN
cord-288020-vhtr3l0w	39	55	high	high	JJ
cord-288020-vhtr3l0w	39	56	risk	risk	NN
cord-288020-vhtr3l0w	39	57	of	of	IN
cord-288020-vhtr3l0w	39	58	in	in	IN
cord-288020-vhtr3l0w	39	59	-	-	HYPH
cord-288020-vhtr3l0w	39	60	hospital	hospital	NN
cord-288020-vhtr3l0w	39	61	morbidity	morbidity	NN
cord-288020-vhtr3l0w	39	62	and	and	CC
cord-288020-vhtr3l0w	39	63	mortality	mortality	NN
cord-288020-vhtr3l0w	39	64	[	[	-LRB-
cord-288020-vhtr3l0w	39	65	7	7	CD
cord-288020-vhtr3l0w	39	66	]	]	-RRB-
cord-288020-vhtr3l0w	39	67	[	[	-LRB-
cord-288020-vhtr3l0w	39	68	8	8	CD
cord-288020-vhtr3l0w	39	69	]	]	-RRB-
cord-288020-vhtr3l0w	39	70	[	[	-LRB-
cord-288020-vhtr3l0w	39	71	9	9	CD
cord-288020-vhtr3l0w	39	72	]	]	-RRB-
cord-288020-vhtr3l0w	39	73	.	.	.
cord-288020-vhtr3l0w	40	1	The	the	DT
cord-288020-vhtr3l0w	40	2	authors	author	NNS
cord-288020-vhtr3l0w	40	3	included	include	VBD
cord-288020-vhtr3l0w	40	4	CRP	CRP	NNP
cord-288020-vhtr3l0w	40	5	,	,	,
cord-288020-vhtr3l0w	40	6	but	but	CC
cord-288020-vhtr3l0w	40	7	did	do	VBD
cord-288020-vhtr3l0w	40	8	not	not	RB
cord-288020-vhtr3l0w	40	9	include	include	VB
cord-288020-vhtr3l0w	40	10	other	other	JJ
cord-288020-vhtr3l0w	40	11	potentially	potentially	RB
cord-288020-vhtr3l0w	40	12	valuable	valuable	JJ
cord-288020-vhtr3l0w	40	13	blood	blood	NN
cord-288020-vhtr3l0w	40	14	biomarkers	biomarker	NNS
cord-288020-vhtr3l0w	40	15	,	,	,
cord-288020-vhtr3l0w	40	16	such	such	JJ
cord-288020-vhtr3l0w	40	17	as	as	IN
cord-288020-vhtr3l0w	40	18	D	D	NNP
cord-288020-vhtr3l0w	40	19	-	-	HYPH
cord-288020-vhtr3l0w	40	20	Dimers	Dimers	NNPS
cord-288020-vhtr3l0w	40	21	,	,	,
cord-288020-vhtr3l0w	40	22	Troponin	Troponin	NNP
cord-288020-vhtr3l0w	40	23	and	and	CC
cord-288020-vhtr3l0w	40	24	Ferritin	ferritin	NN
cord-288020-vhtr3l0w	40	25	.	.	.
cord-288020-vhtr3l0w	41	1	The	the	DT
cord-288020-vhtr3l0w	41	2	proportion	proportion	NN
cord-288020-vhtr3l0w	41	3	of	of	IN
cord-288020-vhtr3l0w	41	4	these	these	DT
cord-288020-vhtr3l0w	41	5	high	high	JJ
cord-288020-vhtr3l0w	41	6	-	-	HYPH
cord-288020-vhtr3l0w	41	7	risk	risk	NN
cord-288020-vhtr3l0w	41	8	patients	patient	NNS
cord-288020-vhtr3l0w	41	9	is	be	VBZ
cord-288020-vhtr3l0w	41	10	relatively	relatively	RB
cord-288020-vhtr3l0w	41	11	small	small	JJ
cord-288020-vhtr3l0w	41	12	but	but	CC
cord-288020-vhtr3l0w	41	13	there	there	EX
cord-288020-vhtr3l0w	41	14	is	be	VBZ
cord-288020-vhtr3l0w	41	15	,	,	,
cord-288020-vhtr3l0w	41	16	nonetheless	nonetheless	RB
cord-288020-vhtr3l0w	41	17	,	,	,
cord-288020-vhtr3l0w	41	18	a	a	DT
cord-288020-vhtr3l0w	41	19	need	need	NN
cord-288020-vhtr3l0w	41	20	to	to	TO
cord-288020-vhtr3l0w	41	21	identify	identify	VB
cord-288020-vhtr3l0w	41	22	them	-PRON-	PRP
cord-288020-vhtr3l0w	41	23	early	early	RB
cord-288020-vhtr3l0w	41	24	in	in	IN
cord-288020-vhtr3l0w	41	25	the	the	DT
cord-288020-vhtr3l0w	41	26	course	course	NN
cord-288020-vhtr3l0w	41	27	of	of	IN
cord-288020-vhtr3l0w	41	28	the	the	DT
cord-288020-vhtr3l0w	41	29	disease	disease	NN
cord-288020-vhtr3l0w	41	30	to	to	TO
cord-288020-vhtr3l0w	41	31	enable	enable	VB
cord-288020-vhtr3l0w	41	32	timely	timely	JJ
cord-288020-vhtr3l0w	41	33	and	and	CC
cord-288020-vhtr3l0w	41	34	individualized	individualized	JJ
cord-288020-vhtr3l0w	41	35	interventions	intervention	NNS
cord-288020-vhtr3l0w	41	36	,	,	,
cord-288020-vhtr3l0w	41	37	such	such	JJ
cord-288020-vhtr3l0w	41	38	as	as	IN
cord-288020-vhtr3l0w	41	39	anti	anti	JJ
cord-288020-vhtr3l0w	41	40	-	-	JJ
cord-288020-vhtr3l0w	41	41	inflammatory	inflammatory	JJ
cord-288020-vhtr3l0w	41	42	or	or	CC
cord-288020-vhtr3l0w	41	43	anti	anti	JJ
cord-288020-vhtr3l0w	41	44	-	-	JJ
cord-288020-vhtr3l0w	41	45	thrombotic	thrombotic	JJ
cord-288020-vhtr3l0w	41	46	pharmacotherapy	pharmacotherapy	NN
cord-288020-vhtr3l0w	41	47	.	.	.
cord-288020-vhtr3l0w	42	1	To	to	IN
cord-288020-vhtr3l0w	42	2	this	this	DT
cord-288020-vhtr3l0w	42	3	point	point	NN
cord-288020-vhtr3l0w	42	4	,	,	,
cord-288020-vhtr3l0w	42	5	preliminary	preliminary	JJ
cord-288020-vhtr3l0w	42	6	analyses	analysis	NNS
cord-288020-vhtr3l0w	42	7	of	of	IN
cord-288020-vhtr3l0w	42	8	the	the	DT
cord-288020-vhtr3l0w	42	9	RECOVERY	recovery	NN
cord-288020-vhtr3l0w	42	10	trial	trial	NN
cord-288020-vhtr3l0w	42	11	data	datum	NNS
cord-288020-vhtr3l0w	42	12	suggest	suggest	VBP
cord-288020-vhtr3l0w	42	13	that	that	IN
cord-288020-vhtr3l0w	42	14	treatment	treatment	NN
cord-288020-vhtr3l0w	42	15	with	with	IN
cord-288020-vhtr3l0w	42	16	dexamethasone	dexamethasone	NN
cord-288020-vhtr3l0w	42	17	reduces	reduce	VBZ
cord-288020-vhtr3l0w	42	18	mortality	mortality	NN
cord-288020-vhtr3l0w	42	19	by~30	by~30	NNP
cord-288020-vhtr3l0w	42	20	%	%	NN
cord-288020-vhtr3l0w	42	21	in	in	IN
cord-288020-vhtr3l0w	42	22	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	42	23	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	42	24	patients	patient	NNS
cord-288020-vhtr3l0w	42	25	with	with	IN
cord-288020-vhtr3l0w	42	26	supplemental	supplemental	JJ
cord-288020-vhtr3l0w	42	27	oxygen	oxygen	NN
cord-288020-vhtr3l0w	42	28	[	[	-LRB-
cord-288020-vhtr3l0w	42	29	10	10	CD
cord-288020-vhtr3l0w	42	30	]	]	-RRB-
cord-288020-vhtr3l0w	42	31	.	.	.
cord-288020-vhtr3l0w	43	1	Predictive	predictive	JJ
cord-288020-vhtr3l0w	43	2	scores	score	NNS
cord-288020-vhtr3l0w	43	3	that	that	WDT
cord-288020-vhtr3l0w	43	4	include	include	VBP
cord-288020-vhtr3l0w	43	5	blood	blood	NN
cord-288020-vhtr3l0w	43	6	biomarkers	biomarker	NNS
cord-288020-vhtr3l0w	43	7	of	of	IN
cord-288020-vhtr3l0w	43	8	inflammation	inflammation	NN
cord-288020-vhtr3l0w	43	9	may	may	MD
cord-288020-vhtr3l0w	43	10	help	help	VB
cord-288020-vhtr3l0w	43	11	to	to	TO
cord-288020-vhtr3l0w	43	12	target	target	VB
cord-288020-vhtr3l0w	43	13	the	the	DT
cord-288020-vhtr3l0w	43	14	subset	subset	NN
cord-288020-vhtr3l0w	43	15	of	of	IN
cord-288020-vhtr3l0w	43	16	patients	patient	NNS
cord-288020-vhtr3l0w	43	17	who	who	WP
cord-288020-vhtr3l0w	43	18	should	should	MD
cord-288020-vhtr3l0w	43	19	receive	receive	VB
cord-288020-vhtr3l0w	43	20	dexamethasone	dexamethasone	NN
cord-288020-vhtr3l0w	43	21	or	or	CC
cord-288020-vhtr3l0w	43	22	other	other	JJ
cord-288020-vhtr3l0w	43	23	anti	anti	JJ
cord-288020-vhtr3l0w	43	24	-	-	JJ
cord-288020-vhtr3l0w	43	25	inflammatory	inflammatory	JJ
cord-288020-vhtr3l0w	43	26	therapy	therapy	NN
cord-288020-vhtr3l0w	43	27	at	at	IN
cord-288020-vhtr3l0w	43	28	an	an	DT
cord-288020-vhtr3l0w	43	29	early	early	JJ
cord-288020-vhtr3l0w	43	30	stage	stage	NN
cord-288020-vhtr3l0w	43	31	of	of	IN
cord-288020-vhtr3l0w	43	32	the	the	DT
cord-288020-vhtr3l0w	43	33	disease	disease	NN
cord-288020-vhtr3l0w	43	34	and	and	CC
cord-288020-vhtr3l0w	43	35	could	could	MD
cord-288020-vhtr3l0w	43	36	aid	aid	VB
cord-288020-vhtr3l0w	43	37	in	in	IN
cord-288020-vhtr3l0w	43	38	the	the	DT
cord-288020-vhtr3l0w	43	39	optimal	optimal	JJ
cord-288020-vhtr3l0w	43	40	design	design	NN
cord-288020-vhtr3l0w	43	41	of	of	IN
cord-288020-vhtr3l0w	43	42	new	new	JJ
cord-288020-vhtr3l0w	43	43	therapeutic	therapeutic	JJ
cord-288020-vhtr3l0w	43	44	trials	trial	NNS
cord-288020-vhtr3l0w	43	45	.	.	.
cord-288020-vhtr3l0w	44	1	With	with	IN
cord-288020-vhtr3l0w	44	2	the	the	DT
cord-288020-vhtr3l0w	44	3	COVID-19	covid-19	JJ
cord-288020-vhtr3l0w	44	4	pandemic	pandemic	NN
cord-288020-vhtr3l0w	44	5	,	,	,
cord-288020-vhtr3l0w	44	6	the	the	DT
cord-288020-vhtr3l0w	44	7	world	world	NN
cord-288020-vhtr3l0w	44	8	is	be	VBZ
cord-288020-vhtr3l0w	44	9	currently	currently	RB
cord-288020-vhtr3l0w	44	10	facing	face	VBG
cord-288020-vhtr3l0w	44	11	a	a	DT
cord-288020-vhtr3l0w	44	12	major	major	JJ
cord-288020-vhtr3l0w	44	13	health	health	NN
cord-288020-vhtr3l0w	44	14	crisis	crisis	NN
cord-288020-vhtr3l0w	44	15	.	.	.
cord-288020-vhtr3l0w	45	1	An	an	DT
cord-288020-vhtr3l0w	45	2	integrative	integrative	JJ
cord-288020-vhtr3l0w	45	3	multi	multi	JJ
cord-288020-vhtr3l0w	45	4	-	-	NN
cord-288020-vhtr3l0w	45	5	parameter	parameter	NN
cord-288020-vhtr3l0w	45	6	stepwise	stepwise	JJ
cord-288020-vhtr3l0w	45	7	approach	approach	NN
cord-288020-vhtr3l0w	45	8	,	,	,
cord-288020-vhtr3l0w	45	9	such	such	JJ
cord-288020-vhtr3l0w	45	10	as	as	IN
cord-288020-vhtr3l0w	45	11	the	the	DT
cord-288020-vhtr3l0w	45	12	one	one	NN
cord-288020-vhtr3l0w	45	13	we	-PRON-	PRP
cord-288020-vhtr3l0w	45	14	propose	propose	VBP
cord-288020-vhtr3l0w	45	15	in	in	IN
cord-288020-vhtr3l0w	45	16	Fig	Fig	NNP
cord-288020-vhtr3l0w	45	17	.	.	.
cord-288020-vhtr3l0w	46	1	1	1	LS
cord-288020-vhtr3l0w	46	2	,	,	,
cord-288020-vhtr3l0w	46	3	may	may	MD
cord-288020-vhtr3l0w	46	4	help	help	VB
cord-288020-vhtr3l0w	46	5	to	to	TO
cord-288020-vhtr3l0w	46	6	optimize	optimize	VB
cord-288020-vhtr3l0w	46	7	the	the	DT
cord-288020-vhtr3l0w	46	8	management	management	NN
cord-288020-vhtr3l0w	46	9	of	of	IN
cord-288020-vhtr3l0w	46	10	patients	patient	NNS
cord-288020-vhtr3l0w	46	11	with	with	IN
cord-288020-vhtr3l0w	46	12	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	46	13	.	.	.
cord-288020-vhtr3l0w	47	1	The	the	DT
cord-288020-vhtr3l0w	47	2	HNC	HNC	NNP
cord-288020-vhtr3l0w	47	3	-	-	HYPH
cord-288020-vhtr3l0w	47	4	LL	LL	NNP
cord-288020-vhtr3l0w	47	5	score	score	NN
cord-288020-vhtr3l0w	47	6	proposed	propose	VBN
cord-288020-vhtr3l0w	47	7	by	by	IN
cord-288020-vhtr3l0w	47	8	Xiao	Xiao	NNP
cord-288020-vhtr3l0w	47	9	et	et	NNP
cord-288020-vhtr3l0w	47	10	al	al	NNP
cord-288020-vhtr3l0w	47	11	.	.	.
cord-288020-vhtr3l0w	48	1	in	in	IN
cord-288020-vhtr3l0w	48	2	EBioMedicine	EBioMedicine	NNP
cord-288020-vhtr3l0w	48	3	is	be	VBZ
cord-288020-vhtr3l0w	48	4	a	a	DT
cord-288020-vhtr3l0w	48	5	promising	promising	JJ
cord-288020-vhtr3l0w	48	6	development	development	NN
cord-288020-vhtr3l0w	48	7	but	but	CC
cord-288020-vhtr3l0w	48	8	needs	need	VBZ
cord-288020-vhtr3l0w	48	9	to	to	TO
cord-288020-vhtr3l0w	48	10	be	be	VB
cord-288020-vhtr3l0w	48	11	further	further	RB
cord-288020-vhtr3l0w	48	12	validated	validate	VBN
cord-288020-vhtr3l0w	48	13	in	in	IN
cord-288020-vhtr3l0w	48	14	other	other	JJ
cord-288020-vhtr3l0w	48	15	independent	independent	JJ
cord-288020-vhtr3l0w	48	16	patient	patient	JJ
cord-288020-vhtr3l0w	48	17	cohorts	cohort	NNS
cord-288020-vhtr3l0w	48	18	in	in	IN
cord-288020-vhtr3l0w	48	19	other	other	JJ
cord-288020-vhtr3l0w	48	20	countries	country	NNS
cord-288020-vhtr3l0w	48	21	and	and	CC
cord-288020-vhtr3l0w	48	22	in	in	IN
cord-288020-vhtr3l0w	48	23	larger	large	JJR
cord-288020-vhtr3l0w	48	24	cohorts	cohort	NNS
cord-288020-vhtr3l0w	48	25	with	with	IN
cord-288020-vhtr3l0w	48	26	mild	mild	JJ
cord-288020-vhtr3l0w	48	27	disease	disease	NN
cord-288020-vhtr3l0w	48	28	who	who	WP
cord-288020-vhtr3l0w	48	29	are	be	VBP
cord-288020-vhtr3l0w	48	30	not	not	RB
cord-288020-vhtr3l0w	48	31	yet	yet	RB
cord-288020-vhtr3l0w	48	32	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	48	33	.	.	.
cord-288020-vhtr3l0w	49	1	Furthermore	furthermore	RB
cord-288020-vhtr3l0w	49	2	,	,	,
cord-288020-vhtr3l0w	49	3	the	the	DT
cord-288020-vhtr3l0w	49	4	addition	addition	NN
cord-288020-vhtr3l0w	49	5	of	of	IN
cord-288020-vhtr3l0w	49	6	other	other	JJ
cord-288020-vhtr3l0w	49	7	relevant	relevant	JJ
cord-288020-vhtr3l0w	49	8	parameters	parameter	NNS
cord-288020-vhtr3l0w	49	9	,	,	,
cord-288020-vhtr3l0w	49	10	symptom	symptom	NN
cord-288020-vhtr3l0w	49	11	duration	duration	NN
cord-288020-vhtr3l0w	49	12	and	and	CC
cord-288020-vhtr3l0w	49	13	other	other	JJ
cord-288020-vhtr3l0w	49	14	blood	blood	NN
cord-288020-vhtr3l0w	49	15	biomarkers	biomarker	NNS
cord-288020-vhtr3l0w	49	16	(	(	-LRB-
cord-288020-vhtr3l0w	49	17	e.g.	e.g.	IN
cord-288020-vhtr3l0w	49	18	Ferritin	ferritin	NN
cord-288020-vhtr3l0w	49	19	,	,	,
cord-288020-vhtr3l0w	49	20	D	D	NNP
cord-288020-vhtr3l0w	49	21	-	-	HYPH
cord-288020-vhtr3l0w	49	22	Dimers	Dimers	NNPS
cord-288020-vhtr3l0w	49	23	or	or	CC
cord-288020-vhtr3l0w	49	24	Troponin	Troponin	NNP
cord-288020-vhtr3l0w	49	25	)	)	-RRB-
cord-288020-vhtr3l0w	49	26	should	should	MD
cord-288020-vhtr3l0w	49	27	be	be	VB
cord-288020-vhtr3l0w	49	28	explored	explore	VBN
cord-288020-vhtr3l0w	49	29	to	to	TO
cord-288020-vhtr3l0w	49	30	determine	determine	VB
cord-288020-vhtr3l0w	49	31	whether	whether	IN
cord-288020-vhtr3l0w	49	32	this	this	DT
cord-288020-vhtr3l0w	49	33	would	would	MD
cord-288020-vhtr3l0w	49	34	improve	improve	VB
cord-288020-vhtr3l0w	49	35	the	the	DT
cord-288020-vhtr3l0w	49	36	predictive	predictive	JJ
cord-288020-vhtr3l0w	49	37	value	value	NN
cord-288020-vhtr3l0w	49	38	of	of	IN
cord-288020-vhtr3l0w	49	39	the	the	DT
cord-288020-vhtr3l0w	49	40	risk	risk	NN
cord-288020-vhtr3l0w	49	41	score	score	NN
cord-288020-vhtr3l0w	49	42	.	.	.
cord-288020-vhtr3l0w	50	1	Another	another	DT
cord-288020-vhtr3l0w	50	2	promising	promising	JJ
cord-288020-vhtr3l0w	50	3	approach	approach	NN
cord-288020-vhtr3l0w	50	4	to	to	TO
cord-288020-vhtr3l0w	50	5	rationalize	rationalize	VB
cord-288020-vhtr3l0w	50	6	and	and	CC
cord-288020-vhtr3l0w	50	7	optimize	optimize	VB
cord-288020-vhtr3l0w	50	8	the	the	DT
cord-288020-vhtr3l0w	50	9	risk	risk	NN
cord-288020-vhtr3l0w	50	10	stratification	stratification	NN
cord-288020-vhtr3l0w	50	11	scores	score	NNS
cord-288020-vhtr3l0w	50	12	for	for	IN
cord-288020-vhtr3l0w	50	13	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	50	14	is	be	VBZ
cord-288020-vhtr3l0w	50	15	to	to	TO
cord-288020-vhtr3l0w	50	16	use	use	VB
cord-288020-vhtr3l0w	50	17	artificial	artificial	JJ
cord-288020-vhtr3l0w	50	18	intelligence	intelligence	NN
cord-288020-vhtr3l0w	50	19	and	and	CC
cord-288020-vhtr3l0w	50	20	machine	machine	NN
cord-288020-vhtr3l0w	50	21	learning	learn	VBG
cord-288020-vhtr3l0w	50	22	to	to	TO
cord-288020-vhtr3l0w	50	23	select	select	VB
cord-288020-vhtr3l0w	50	24	and	and	CC
cord-288020-vhtr3l0w	50	25	include	include	VB
cord-288020-vhtr3l0w	50	26	the	the	DT
cord-288020-vhtr3l0w	50	27	most	most	RBS
cord-288020-vhtr3l0w	50	28	powerful	powerful	JJ
cord-288020-vhtr3l0w	50	29	and	and	CC
cord-288020-vhtr3l0w	50	30	informative	informative	JJ
cord-288020-vhtr3l0w	50	31	clinical	clinical	JJ
cord-288020-vhtr3l0w	50	32	factors	factor	NNS
cord-288020-vhtr3l0w	50	33	and	and	CC
cord-288020-vhtr3l0w	50	34	blood	blood	NN
cord-288020-vhtr3l0w	50	35	biomarkers	biomarker	NNS
cord-288020-vhtr3l0w	50	36	into	into	IN
cord-288020-vhtr3l0w	50	37	the	the	DT
cord-288020-vhtr3l0w	50	38	final	final	JJ
cord-288020-vhtr3l0w	50	39	score	score	NN
cord-288020-vhtr3l0w	50	40	.	.	.
cord-288020-vhtr3l0w	51	1	Developing	develop	VBG
cord-288020-vhtr3l0w	51	2	an	an	DT
cord-288020-vhtr3l0w	51	3	easily	easily	RB
cord-288020-vhtr3l0w	51	4	applicable	applicable	JJ
cord-288020-vhtr3l0w	51	5	and	and	CC
cord-288020-vhtr3l0w	51	6	reliable	reliable	JJ
cord-288020-vhtr3l0w	51	7	clinical	clinical	JJ
cord-288020-vhtr3l0w	51	8	tool	tool	NN
cord-288020-vhtr3l0w	51	9	to	to	TO
cord-288020-vhtr3l0w	51	10	predict	predict	VB
cord-288020-vhtr3l0w	51	11	patient	patient	JJ
cord-288020-vhtr3l0w	51	12	outcome	outcome	NN
cord-288020-vhtr3l0w	51	13	at	at	IN
cord-288020-vhtr3l0w	51	14	an	an	DT
cord-288020-vhtr3l0w	51	15	early	early	JJ
cord-288020-vhtr3l0w	51	16	disease	disease	NN
cord-288020-vhtr3l0w	51	17	stage	stage	NN
cord-288020-vhtr3l0w	51	18	may	may	MD
cord-288020-vhtr3l0w	51	19	dramatically	dramatically	RB
cord-288020-vhtr3l0w	51	20	improve	improve	VB
cord-288020-vhtr3l0w	51	21	the	the	DT
cord-288020-vhtr3l0w	51	22	management	management	NN
cord-288020-vhtr3l0w	51	23	of	of	IN
cord-288020-vhtr3l0w	51	24	patients	patient	NNS
cord-288020-vhtr3l0w	51	25	,	,	,
cord-288020-vhtr3l0w	51	26	while	while	IN
cord-288020-vhtr3l0w	51	27	ensuring	ensure	VBG
cord-288020-vhtr3l0w	51	28	optimal	optimal	JJ
cord-288020-vhtr3l0w	51	29	and	and	CC
cord-288020-vhtr3l0w	51	30	rationale	rationale	NN
cord-288020-vhtr3l0w	51	31	utilization	utilization	NN
cord-288020-vhtr3l0w	51	32	of	of	IN
cord-288020-vhtr3l0w	51	33	health	health	NN
cord-288020-vhtr3l0w	51	34	care	care	NN
cord-288020-vhtr3l0w	51	35	resources	resource	NNS
cord-288020-vhtr3l0w	51	36	and	and	CC
cord-288020-vhtr3l0w	51	37	providers	provider	NNS
cord-288020-vhtr3l0w	51	38	.	.	.
cord-288020-vhtr3l0w	51	39	 	 	_SP
cord-288020-vhtr3l0w	52	1	Authors	author	NNS
cord-288020-vhtr3l0w	52	2	have	have	VBP
cord-288020-vhtr3l0w	52	3	nothing	nothing	NN
cord-288020-vhtr3l0w	52	4	to	to	TO
cord-288020-vhtr3l0w	52	5	disclose	disclose	VB
cord-288020-vhtr3l0w	52	6	.	.	.
cord-288020-vhtr3l0w	53	1	Development	development	NN
cord-288020-vhtr3l0w	53	2	and	and	CC
cord-288020-vhtr3l0w	53	3	validation	validation	NN
cord-288020-vhtr3l0w	53	4	of	of	IN
cord-288020-vhtr3l0w	53	5	the	the	DT
cord-288020-vhtr3l0w	53	6	HNC	HNC	NNP
cord-288020-vhtr3l0w	53	7	-	-	HYPH
cord-288020-vhtr3l0w	53	8	LL	LL	NNP
cord-288020-vhtr3l0w	53	9	score	score	NN
cord-288020-vhtr3l0w	53	10	for	for	IN
cord-288020-vhtr3l0w	53	11	predicting	predict	VBG
cord-288020-vhtr3l0w	53	12	the	the	DT
cord-288020-vhtr3l0w	53	13	severity	severity	NN
cord-288020-vhtr3l0w	53	14	of	of	IN
cord-288020-vhtr3l0w	53	15	coronavirus	coronavirus	NN
cord-288020-vhtr3l0w	53	16	disease	disease	NN
cord-288020-vhtr3l0w	53	17	2019	2019	CD
cord-288020-vhtr3l0w	53	18	Sociodemographic	sociodemographic	JJ
cord-288020-vhtr3l0w	53	19	,	,	,
cord-288020-vhtr3l0w	53	20	clinical	clinical	JJ
cord-288020-vhtr3l0w	53	21	and	and	CC
cord-288020-vhtr3l0w	53	22	laboratory	laboratory	NN
cord-288020-vhtr3l0w	53	23	factors	factor	NNS
cord-288020-vhtr3l0w	53	24	on	on	IN
cord-288020-vhtr3l0w	53	25	admission	admission	NN
cord-288020-vhtr3l0w	53	26	associated	associate	VBN
cord-288020-vhtr3l0w	53	27	with	with	IN
cord-288020-vhtr3l0w	53	28	COVID-19	covid-19	JJ
cord-288020-vhtr3l0w	53	29	mortality	mortality	NN
cord-288020-vhtr3l0w	53	30	in	in	IN
cord-288020-vhtr3l0w	53	31	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	53	32	patients	patient	NNS
cord-288020-vhtr3l0w	53	33	:	:	:
cord-288020-vhtr3l0w	53	34	a	a	DT
cord-288020-vhtr3l0w	53	35	retrospective	retrospective	JJ
cord-288020-vhtr3l0w	53	36	observational	observational	JJ
cord-288020-vhtr3l0w	53	37	study	study	NN
cord-288020-vhtr3l0w	53	38	Clinical	Clinical	NNP
cord-288020-vhtr3l0w	53	39	Features	Features	NNPS
cord-288020-vhtr3l0w	54	1	Predicting	predict	VBG
cord-288020-vhtr3l0w	54	2	Mortality	Mortality	NNP
cord-288020-vhtr3l0w	54	3	Risk	risk	NN
cord-288020-vhtr3l0w	54	4	in	in	IN
cord-288020-vhtr3l0w	54	5	Patients	patient	NNS
cord-288020-vhtr3l0w	54	6	With	with	IN
cord-288020-vhtr3l0w	54	7	Viral	Viral	NNP
cord-288020-vhtr3l0w	54	8	Pneumonia	pneumonia	NN
cord-288020-vhtr3l0w	54	9	:	:	:
cord-288020-vhtr3l0w	54	10	the	the	DT
cord-288020-vhtr3l0w	54	11	MuLBSTA	MuLBSTA	NNP
cord-288020-vhtr3l0w	54	12	Score	Score	NNP
cord-288020-vhtr3l0w	54	13	Applicability	Applicability	NNP
cord-288020-vhtr3l0w	54	14	of	of	IN
cord-288020-vhtr3l0w	54	15	the	the	DT
cord-288020-vhtr3l0w	54	16	CURB-65	curb-65	JJ
cord-288020-vhtr3l0w	54	17	pneumonia	pneumonia	NN
cord-288020-vhtr3l0w	54	18	severity	severity	NN
cord-288020-vhtr3l0w	54	19	score	score	NN
cord-288020-vhtr3l0w	54	20	for	for	IN
cord-288020-vhtr3l0w	54	21	outpatient	outpatient	NN
cord-288020-vhtr3l0w	54	22	treatment	treatment	NN
cord-288020-vhtr3l0w	54	23	of	of	IN
cord-288020-vhtr3l0w	54	24	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	54	25	Comparison	Comparison	NNP
cord-288020-vhtr3l0w	54	26	of	of	IN
cord-288020-vhtr3l0w	54	27	CRB-65	CRB-65	NNP
cord-288020-vhtr3l0w	54	28	and	and	CC
cord-288020-vhtr3l0w	54	29	quick	quick	JJ
cord-288020-vhtr3l0w	54	30	sepsis	sepsis	NN
cord-288020-vhtr3l0w	54	31	-	-	HYPH
cord-288020-vhtr3l0w	54	32	related	relate	VBN
cord-288020-vhtr3l0w	54	33	organ	organ	NN
cord-288020-vhtr3l0w	54	34	failure	failure	NN
cord-288020-vhtr3l0w	54	35	assessment	assessment	NN
cord-288020-vhtr3l0w	54	36	for	for	IN
cord-288020-vhtr3l0w	54	37	predicting	predict	VBG
cord-288020-vhtr3l0w	54	38	the	the	DT
cord-288020-vhtr3l0w	54	39	need	need	NN
cord-288020-vhtr3l0w	54	40	for	for	IN
cord-288020-vhtr3l0w	54	41	intensive	intensive	JJ
cord-288020-vhtr3l0w	54	42	respiratory	respiratory	NN
cord-288020-vhtr3l0w	54	43	or	or	CC
cord-288020-vhtr3l0w	54	44	vasopressor	vasopressor	NN
cord-288020-vhtr3l0w	54	45	support	support	NN
cord-288020-vhtr3l0w	54	46	in	in	IN
cord-288020-vhtr3l0w	54	47	patients	patient	NNS
cord-288020-vhtr3l0w	54	48	with	with	IN
cord-288020-vhtr3l0w	54	49	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	54	50	Presenting	present	VBG
cord-288020-vhtr3l0w	54	51	characteristics	characteristic	NNS
cord-288020-vhtr3l0w	54	52	,	,	,
cord-288020-vhtr3l0w	54	53	comorbidities	comorbiditie	NNS
cord-288020-vhtr3l0w	54	54	,	,	,
cord-288020-vhtr3l0w	54	55	and	and	CC
cord-288020-vhtr3l0w	54	56	outcomes	outcome	NNS
cord-288020-vhtr3l0w	54	57	among	among	IN
cord-288020-vhtr3l0w	54	58	5700	5700	CD
cord-288020-vhtr3l0w	54	59	patients	patient	NNS
cord-288020-vhtr3l0w	54	60	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	54	61	with	with	IN
cord-288020-vhtr3l0w	54	62	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	54	63	in	in	IN
cord-288020-vhtr3l0w	54	64	the	the	DT
cord-288020-vhtr3l0w	54	65	New	New	NNP
cord-288020-vhtr3l0w	54	66	York	York	NNP
cord-288020-vhtr3l0w	54	67	City	City	NNP
cord-288020-vhtr3l0w	54	68	Area	Area	NNP
cord-288020-vhtr3l0w	54	69	Association	Association	NNP
cord-288020-vhtr3l0w	54	70	of	of	IN
cord-288020-vhtr3l0w	54	71	cardiac	cardiac	JJ
cord-288020-vhtr3l0w	54	72	injury	injury	NN
cord-288020-vhtr3l0w	54	73	with	with	IN
cord-288020-vhtr3l0w	54	74	mortality	mortality	NN
cord-288020-vhtr3l0w	54	75	in	in	IN
cord-288020-vhtr3l0w	54	76	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	54	77	patients	patient	NNS
cord-288020-vhtr3l0w	54	78	with	with	IN
cord-288020-vhtr3l0w	54	79	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	54	80	in	in	IN
cord-288020-vhtr3l0w	54	81	Wuhan	Wuhan	NNP
cord-288020-vhtr3l0w	54	82	,	,	,
cord-288020-vhtr3l0w	54	83	China	China	NNP
cord-288020-vhtr3l0w	54	84	Abnormal	abnormal	JJ
cord-288020-vhtr3l0w	54	85	coagulation	coagulation	NN
cord-288020-vhtr3l0w	54	86	parameters	parameter	NNS
cord-288020-vhtr3l0w	54	87	are	be	VBP
cord-288020-vhtr3l0w	54	88	associated	associate	VBN
cord-288020-vhtr3l0w	54	89	with	with	IN
cord-288020-vhtr3l0w	54	90	poor	poor	JJ
cord-288020-vhtr3l0w	54	91	prognosis	prognosis	NN
cord-288020-vhtr3l0w	54	92	in	in	IN
cord-288020-vhtr3l0w	54	93	patients	patient	NNS
cord-288020-vhtr3l0w	54	94	with	with	IN
cord-288020-vhtr3l0w	54	95	novel	novel	JJ
cord-288020-vhtr3l0w	54	96	coronavirus	coronavirus	NN
cord-288020-vhtr3l0w	54	97	pneumonia	pneumonia	NN
cord-288020-vhtr3l0w	54	98	COVID-19	COVID-19	NNP
cord-288020-vhtr3l0w	54	99	:	:	:
cord-288020-vhtr3l0w	54	100	consider	consider	VB
cord-288020-vhtr3l0w	54	101	cytokine	cytokine	JJ
cord-288020-vhtr3l0w	54	102	storm	storm	NN
cord-288020-vhtr3l0w	54	103	syndromes	syndrome	NNS
cord-288020-vhtr3l0w	54	104	and	and	CC
cord-288020-vhtr3l0w	54	105	immunosuppression	immunosuppression	NN
cord-288020-vhtr3l0w	54	106	Effect	effect	NN
cord-288020-vhtr3l0w	54	107	of	of	IN
cord-288020-vhtr3l0w	54	108	dexamethasone	dexamethasone	NN
cord-288020-vhtr3l0w	54	109	in	in	IN
cord-288020-vhtr3l0w	54	110	hospitalized	hospitalize	VBN
cord-288020-vhtr3l0w	54	111	patients	patient	NNS
cord-288020-vhtr3l0w	54	112	with	with	IN
cord-288020-vhtr3l0w	54	113	COVID-19	covid-19	NN
cord-288020-vhtr3l0w	54	114	:	:	:
cord-288020-vhtr3l0w	54	115	preliminary	preliminary	JJ